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INTRODUCTION 
In pregnancy, successful outcome for both mother and child is largely dependent on the 
adequate cooperation between the semi-allogenous fetus and its host organism. Human 
placentation is unique in that it results in an intimate contact between fetal trophoblast 
cells, or their debris, and maternal systemic circulation. It is in the failure of one or more of 
the steps in this intricate interaction that not only preeclampsia, but all the great obstetric 
disorders, are thought to find their pathogenesis. 
Preeclampsia is a multi-organ disease which occurs in about 2-8% of pregnancies [1]. The 
disease is traditionally defined as new onset hypertension with significant proteinuria [2]. It 
can also occur in the absence of proteinuria, with diagnostic criteria consisting of hemolytic 
anemia, elevated liver enzymes and low platelets (HELLP syndrome) [2]. The placenta is 
required for its development and its removal is currently the only curative measure for 
the disease. The disorder has a significant impact on maternal and perinatal morbidity 
worldwide. Hypertensive disorders of pregnancy are still the leading cause of maternal 
death in the Netherlands [3]. Globally, preeclampsia leads to 14% of maternal death [4] and 
5-37% of perinatal death, with outcome largely dependent on the development status of the 
country [5]. Additionally, the disease and its complications are responsible for 9-35% of fetal 
growth restriction [6] and up to 20% of premature deliveries [1]. 
Figure 1 | Spiral artery adaptation in normal and hypertensive pregnancy. In normal pregnancy 
the small caliber muscular spiral arteries of the decidua and myometrium underlying the 
placenta, are remodeled into large caliber vessels lacking smooth muscle cells. Preeclampsia 
is associated with inadequate remodeling with spiral artery adaptation limited to the decidual 
layer. Fetal trophoblast cells (EVT) and maternal uterine natural killers cells (NK cell) are 
thought to play a vital role in spiral artery adaptation.  
Source: Published October 18, 2004 // JEM vol. 200 no. 8 951-955. The Rockefeller University 
Press, doi: 10.1084/jem.20041783.
209991-L-bw-stevens
9
Introduction and outline of the thesis
1
The highly variable clinical presentation of preeclampsia has led to the proposal of a hetero- 
geneous nature of the disease [7]. Despite intensive research no single causative mecha-
nism for the disease has been discovered.  Although defective remodeling of the spiral 
arteries is considered an important factor in its pathophysiology (Figure 1), this finding is 
neither ubiquitous in preeclampsia nor limited to hypertensive diseases of pregnancy.
Early onset preeclampsia (<34 weeks gestational age) is more frequently associated with 
placental pathology and fetal growth restriction than late onset preeclampsia, which has 
led to the suggestion of two subtypes of the disease [8, 9]. Additionally, the distinction 
between maternal and placental preeclampsia has been proposed [7]. Pregnancy itself 
is an immuno-logical and inflammatory burden, with placental microparticles constantly 
being cleared into the maternal circulation. As placental and spiral artery pathology is often 
absent especially in late onset preeclampsia, it has been suggested that it is this burden 
which causes an exaggerated maternal response in overly susceptible hosts, such as 
patients with pre-existing medical disease, resulting in the endothelial dysfunction seen in 
preeclampsia [9]. 
Figure 2 | Decidua basalis of a woman with preeclampsia. Decidual vasculopathy of spiral 
artery with fibrinoid necrosis and foam cells. (Hematoxylin & Eosin, 100x).  
Source: Radboud university medical center.
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In a subgroup of about 40-50% of women with preeclampsia pathological changes known 
as decidual vasculopathy (DV) or acute atherosis develop in the spiral arteries [10]. These 
lesions are morphologically characterized by fibrinoid necrosis and foam cell infiltration 
(Figure 2), with or without perivascular lymphocytic infiltration and thrombosis, of arteries 
in the placental bed (decidua basalis and underlying upper layer of the myometrium) and 
decidua parietalis underlying the fetal membranes (figure 3) [11]. The lesions are often, but 
not universally, seen in non-remodeled spiral arteries [12]. 
Theoretically, DV, like non-physiological remodeling, could further disturb spiral artery 
function and therefore have an additional negative effect on uteroplacental circulation. 
Ultimately, this could lead to more severe disease and worse outcome for both mother and 
child. Studies on this subject have not been entirely conclusive so far.  Some researchers 
observed an association between DV and a shorter gestational age [10] and a lower birth 
weight [13]. Khong et al. (1987) did not find a correlation of DV with proteinuria, severity 
and duration of hypertension preeclamptic women [10], while others did observe an 
association between presence of lesions and severity of the maternal disease [14]. The 
lesions have been related to placental infarction and intraplacental hematoma [15, 16]. A 
history of particularly early preeclampsia is associated with increased recurrence rates of 
hypertensive diseases of pregnancy as well as adverse pregnancy outcome in general [17, 
18]. Nothing is known about the long term consequences of the lesions. 
The etiology of DV and way in which the lesions relate to the pathophysiology of 
preeclampsia is unknown. As the lesions are found in a proportion of patients with DV, 
one could theorize they might be part of a subtype of preeclampsia with a separate 
etiology. The fact that the lesions, like non-physiological remodeling, are not limited to 
preeclampsia, but also have been described in normotensive fetal growth restriction [19] 
and auto-immune disease [20], suggests their etiology is not part of a process related to 
preeclampsia only. Based on the morphological similarity of the foam cell infiltration in DV 
to atherosclerotic lesions, a related etiology has been proposed [21]. Indeed the lesions 
themselves were initially named acute atherosis because of this [22]. Women with a history 
of early onset preeclampsia have increased long term risk of cardiovascular disease, 
suggesting either the two diseases share risk factors or preeclampsia itself has a long 
term effect on vascular function [23]. How DV relates to cardiovascular risk is unknown. 
Based on the morphological similarity of the lesions to vessels from rejected transplant 
tissue, a pathophysiological mechanism based on an immunological reaction has been 
proposed for DV [24]. Perivascular lymphocytic infiltrate is often observed in the lesions, 
suggesting an inflammatory reaction is involved, but whether this is causative or reactive 
is unknown. Studies performed in the 80s noted the presence of immunoglobulins and 
component factors in DV lesions [24]. The maternal immune system is thought to be vital 
to the regulation of adequate placentation. Uterine natural killer cells make up about 70% 
of maternal immune cells in the decidua and aberrances in their cell populations were 
observed in preeclampsia [25, 26]. The characteristics of uterine natural killer cells in DV and 
the way they interact with fetally derived trophoblast cells, which are also proposed to be 
disrupted in preeclampsia, are unknown. 
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Figure 3 | Anatomy of uterus and placenta. Fetal placenta with underlying maternal decidua 
basalis and myometrium. Maternal decidua parietalis underlying the fetal membranes.  
Source: Radboud university medical center.
OUTLINE OF THE THESIS
This thesis is dedicated to studying DV in preeclampsia. DV is observed in a subset 
of women with preeclampsia. It is unclear whether the lesions are associated with 
adverse clinical outcome or a higher percentage of placental pathology. A history of early 
preeclampsia is associated with increased risk of future pregnancy complications and of 
cardiovascular disease but how this relates to DV is unknown. The etiology of the lesions 
is not known but mechanisms related to atherosclerosis and immune reactions have been 
proposed. We analyzed various aspects of the lesions by formulating the following research 
questions:
1. Does DV in preeclampsia relate to worse maternal and neonatal outcome, as well 
as increased placental pathology? (Chapter 2)
2. Do number of vessels affected, their location and individual morphological 
characteristics correlate to clinical outcome and placental pathology in 
preeclampsia? (Chapter 3)
3. Do women with a history of preeclampsia with DV have increased recurrence risk 
and increased long term obstetric complications? (Chapter 4)
4. Do women with a history of preeclampsia with DV have increased cardiovascular 
risk? (Chapter 5)
5. Does DV relate to aberrant uterine natural killer cell and trophoblast cell 
characteristics? (Chapter 6)
6. How does the literature available on DV combine with our research to form a novel 
hypothesis on the pathophysiology of DV? (Chapter 7)
209991-L-bw-stevens
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PATIENT GROUPS
The patient groups in this thesis are interrelated. For our studies on clinical outcome 
and placental pathology (Chapters 2 and 3), our first patient group was selected based 
on availability of clinical data and placental material from women who delivered at the 
Radboud university medical center between the years 1995-2000. A second patient group 
was selected for our study on cardiovascular risk (Chapter 5). The cardiovascular risk data 
was obtained from a cohort of women between the years 2001-2010, which was then 
matched with the pathology database to obtain the necessary placental material. Cases 
from both patient groups were used for our studies on long term outcome (Chapter 4) and 
decidual cell populations (Chapter 6). All women for which current contact information 
could be obtained were contact for our long term outcome study. Cases for our decidual 
cell population study were selected based on the presence of representative lesions. 
Additionally, as little is known about decidual cell populations in the normal placenta, 
preterm and term controls were selected for this study, based on availability of placental 
material of deliveries between 2000-2008 from uncomplicated term pregnancies and 
preterm pregnancies without signs of chorioamnionitis. 
209991-L-bw-stevens
13
Introduction and outline of the thesis
1
REFERENCES
1. Duley, L, The global impact of pre-eclampsia 
and eclampsia. Semin Perinatol, 2009 33(3): 
p. 130-7.
2. Brown, M.A., et al., The classification and 
diagnosis of the hypertensive disorders of 
pregnancy: statement from the International 
Society for the Study of Hypertension in 
Pregnancy (ISSHP). Hypertens Pregnancy, 
2001. 20(1): p. IX-XIV.
3. Schutte, J.M., et al., Rise in maternal 
mortality in the Netherlands. Bjog., 2010. 
117(4): p. 399-406.
4. Say L, et el. Global causes of maternal 
death: a WHO systematic analysis. Lancet 
Glob Health. 2014 Jun;2(6):e323-33. doi: 
10.1016/S2214-109X(14)70227-X. Epub 
2014 May 5.
5. Yucesoy, G., et al., Maternal and perinatal 
outcome in pregnancies complicated with 
hypertensive disorder of pregnancy: a seven 
year experience of a tertiary care center. 
Arch Gynecol Obstet., 2005. 273(1): p. 43-9. 
Epub 2005 Apr 15.
6. Gruslin, A. and B. Lemyre, Pre-eclampsia: 
fetal assessment and neonatal outcomes. 
Best Pract Res Clin Obstet Gynaecol., 2011. 
25(4): p. 491-507. 
7. Ness, R.B. and J.M. Roberts, Heterogeneous 
causes constituting the single syndrome 
of preeclampsia: a hypothesis and its 
implications. Am J Obstet Gynecol, 1996. 
175(5): p. 1365-70.
8. Yung, H.W., et al., Differential activation 
of placental unfolded protein response 
pathways implies heterogeneity in causa-
tion of early- and late-onset pre-eclampsia. 
J Pathol., 2014. 234(2): p. 262-76. 
9. Redman, C.W. and I.L. Sargent, Placental 
debris, oxidative stress and pre-eclampsia. 
Placenta., 2000. 21(7): p. 597-602.
10. Khong, T.Y., J.M. Pearce, and W.B. 
Robertson, Acute atherosis in preeclampsia: 
maternal determinants and fetal outcome 
in the presence of the lesion. Am J Obstet 
Gynecol, 1987. 157(2): p.360-3.
11. Benirschke K, K.P., Baergen R., in Pathology 
of the human placenta, K.P. Benirschke K, 
Baergen R, Editor. 2006, Springer Science þ 
Business Media: New York. p. p. 605-12.
12. Meekins, J.W., et al., A study of placental 
bed spiral arteries and trophoblast invasion 
in normal and severe pre-eclamptic 
pregnancies. Br J Obstet Gynaecol, 1994. 
101(8): p. 669-74.
13. McFadyen, I.R., A.B. Price, and R.T. Geirsson, 
The relation of birthweight to histological 
appearances in vessels of the placental 
bed. Br J Obstet Gynaecol, 1986. 93(5): p. 
476-81.
14. Maqueo, M., J. Chavezazuela, and M. 
Dosaldelavega, PLACENTAL PATHOLOGY IN 
ECLAMPSIA AND PREECLAMPSIA. Obstet 
Gynecol, 1964. 24: p. 350-6.
15. Brosens, I. and M. Renaer, On the 
pathogenesis of placental infarcts in 
pre-eclampsia. J Obstet Gynaecol Br 
Commonw, 1972. 79(9): p. 794-9.
16. Fitzgerald, B., et al., Rounded intraplacental 
haematomas due to decidual vasculopathy 
have a distinctive morphology. J Clin Pathol, 
2011. 64(8): p. 729-32.
17. Wikstrom, A.K., O. Stephansson, and S. 
Cnattingius, Previous preeclampsia and 
risks of adverse outcomes in subsequent 
nonpreeclamptic pregnancies. Am J Obstet 
Gynecol., 2011 Feb;204(2):148.e1-6
18. Melamed, N., et al., Risk for recurrence of 
preeclampsia and outcome of subsequent 
pregnancy in women with preeclampsia 
in their first pregnancy. J Matern Fetal 
Neonatal Med. 2012 Nov;25(11):2248-51.
209991-L-bw-stevens
14
Chapter 1
19. Khong, T.Y., Acute atherosis in pregnancies 
complicated by hypertension, small-for-
gestational age infants, and diabetes 
mellitus. Arch Pathol Lab Med, 1991. 115(7): 
p. 722-5.
20. Ogishima, D., et al., Placental pathology 
in systemic lupus erythematosus with 
antiphospholipid antibodies. Pathol Int, 
2000. 50(3): p. 224-9.
21. Staff, A.C. and C.W. Redman, IFPA Award 
in Placentology Lecture: preeclampsia, the 
decidual battleground and future maternal 
cardiovascular disease. Placenta., 2014. 
35(Suppl): p. S26-31.
22. Zeek, P.M. and N.S. Assali, Vascular 
changes in the decidua associated with 
eclamptogenic toxemia of pregnancy. Am J 
Clin Pathol, 1950. 20(12): p. 1099-1109.
23. Bellamy, L., et al., Pre-eclampsia and risk of 
cardiovascular disease and cancer in later 
life: systematic review and meta-analysis. 
BMJ, 2007. 335(7627): p. 974.
24. Labarrere, C.A., Acute atherosis. A 
histopathological hallmark of immune 
aggression? Placenta, 1988. 9(1): p. 95-108.
25. Tessier, D.R., J. Yockell-Lelievre, and A. 
Gruslin, Uterine Spiral Artery Remodeling: 
The Role of Uterine Natural Killer Cells 
and Extravillous Trophoblasts in Normal 
and High-Risk Human Pregnancies. Am J 
Reprod Immunol, 2014 Dec 3. doi: 10.1111/
aji.12345
26. Bachmayer, N., et al., Aberrant uterine 
natural killer (NK)-cell expression and 
altered placental and serum levels of the 
NK-cell promoting cytokine interleukin-12 
in pre-eclampsia. Am J Reprod Immunol., 
2006. 56(5-6): p. 292-301.
209991-L-bw-stevens
Decidual vasculopathy and 
adverse perinatal outcome 
in preeclamptic pregnancy
D.U. Stevens, S. Al-Nasiry, J. Bulten, M.E.A. Spaanderman
Stevens DU, Al-Nasiry S, Bulten J, Spaanderman ME. Decidual vasculopathy and adverse 
perinatal outcome in preeclamptic pregnancy. Placenta, 2012. 33(8): p. 630-3.
2
209991-L-bw-stevens
16
Chapter 2
ABSTRACT 
Objective
Decidual vasculopathy (DV) describes pathological findings seen in the spiral arteries in 
preeclampsia (PE). Morphologically, DV is characterized by fibrinoid necrosis and foamy 
macrophages within the vessel walls. The impact of the lesions on clinical outcome and 
placental pathology is unclear. We compared cases with DV to cases without these lesions 
on clinical outcome and placental histology in PE.
Study design
Placental sections from 107 patients admitted with PE at the Radboud university medical 
center, during the years 1995-2000, were analyzed. 25 cases were excluded due to 
incomplete records or multiple pregnancy. Cases with DV (n= 41) and without DV (n= 41) 
were compared for various clinical and placental histological parameters, using Mann-
Whitney test. P-value < 0.05 was considered significant.
Results
Clinically, DV related to higher diastolic blood pressure, shorter gestational age, lower 
birth weight and lower umbilical artery pH. Histologically, DV related to more accelerated 
villous maturity and perivascular inflammatory cell infiltration. No differences were found 
in maternal biochemical variables (protein-to-creatinine ratio, constituents of HELLP 
syndrome), fetal-maternal interface parameters (placenta weight, infarctions, hematoma, 
calcifications), or neonatal outcome measures (birth weight centile, APGAR scores, and 
perinatal death).
Conclusions
In PE, the presence of DV related to placental accelerated villous maturity, perivascular 
inflammatory cell infiltration, and adverse maternal and fetal outcome without affecting 
neonatal survival. Whether or not DV results from or raises the risk on severe preeclampsia 
remains to be elucidated.
209991-L-bw-stevens
17
Decidual vasculopathy and adverse perinatal outcome in preeclamptic pregnancy
2
INTRODUCTION
Preeclampsia is a hypertensive disease of pregnancy, defined by the new onset of elevated 
blood pressure and proteinuria after 20 weeks of gestation that affects 2-8% percent of 
pregnancies. It is a systemic endothelial disease that consequently exhibits a wide range 
of manifestations, including pathology of the liver and central nervous system [1]. It is a 
disease with serious consequences for both mother and fetus, with 10%-15% of direct 
maternal deaths associated with preeclampsia and eclampsia as well as 25% of fetal and 
neonatal death in developing countries [1]. Additionally, the disease is responsible for up 
to 12% of infants born small for gestational age and 20% of those born preterm [1]. The 
pathogenesis of preeclampsia is thought to originate from the placental bed, with a defect 
in the remodeling of the spiral arteries, a physiological change necessary to preserve 
adequate blood flow towards the placenta under all conditions [2]. The lack of spiral artery 
remodeling causes pathological changes in the placenta, a process which is not yet fully 
understood [2]. Eventually, factors released by the diseased placenta lead to systemic 
endothelial dysfunction and the clinical disease of preeclampsia [2].
In a proportion of patients with preeclampsia, spiral arteries unaffected by physiological 
remodeling of pregnancy undergo pathological changes. These changes are referred to as 
decidual vasculopathy, or acute atherosis. Although there has been some debate on the 
different morphological features of decidual vasculopathy, including their location and role 
in its pathogenesis, and relevant terminology used [3, 4], two characteristic lesions are 
described, namely, fibrinoid necrosis of spiral arteries and accumulation of foamy macro-
phages within the vessel wall (Fig. 1) [5, 6]. Other features are perivascular lymphocytic 
infiltrate and thrombosis (Fig. 2) [5, 6]. The etiology of decidual vasculopathy is unknown.
Decidual vasculopathy is characteristically described in patients with preeclampsia [3, 4, 7], 
but has also been identified in the decidua of pregnancies complicated by fetal growth 
restriction [3, 4, 8], diabetes mellitus [4], gestational [9] and chronic hypertension [10], and 
systemic lupus erythematosus [11], although some studies have failed to confirm the 
presence of these lesions in cases with fetal growth restriction and diabetes mellitus [3, 12]. 
 An explanation for this can be sought in variation of number of cases, in study design 
and in whether the study included both the decidua basalis and the decidua parietalis. 
In preeclampsia, decidual vasculopathy has been consistently reported, although the 
percentage of cases with lesions varies amongst different studies [13-15].
209991-L-bw-stevens
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Figure 1 | A. Decidual vasculopathy with fibrinoid necrosis (star) and foam cells (Hematoxylin & 
Eosin 100x). B. Foam cell (Hematoxylin & Eosin 400x).  
Source: Radboud university medical center.
Clinical and placental pathological implications of decidual vasculopathy remain largely 
unclear. Khong et al. (1987) found no difference in degree of proteinuria, severity and 
duration of hypertension or in fetal outcome in preeclamptic women with and without 
decidual vasculopathy [13], while others did observe an association between presence of 
lesions and severity of the maternal disease [14], lower birth weight [16, 17] and shorter 
gestational age [18]. Brosens et al. (1972) described an association between decidual 
vasculopathy and the presence of placental infarction [19]. Additionally, Fitzgerald et al. 
(2011) described an association of the lesions with intraplacental hematomas [20].
In this study, we tested the hypothesis that in preeclampsia the presence of decidual 
vasculopathy is associated with severe maternal disease and adverse neonatal outcome. 
In addition, we tested the hypothesis that decidual vasculopathy is associated with more 
severe placental pathology. We therefore analyzed the association of decidual vasculopathy 
in preeclampsia with a set of maternal and perinatal clinical parameters, to indicate disease 
severity and outcome, and with a set of histological placental parameters, to indicate 
placental pathology.
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Figure 2 | Decidual vasculopathy with fibrinoid necrosis, foam cells (arrow), perivascular 
lymfocytic infiltration (star) (Hematoxylin & Eosin 50x).
Source: Radboud university medical center.
MATERIALS AND METHODS 
Sample collection and clinical parameters
We retrospectively analyzed clinical and placental histological data gathered from patients, 
admitted with preeclampsia at the tertiary referral centre Radboud university medical cen-
ter, during the years 1995-2000, whose placentas had been histopathologically analyzed.
An initial number of 107 cases were available. Final analysis was performed after exclusion 
of 25 cases with incomplete data and multiple pregnancies. Consequently, 82 patients 
could be included in our study. The prevalence of decidual vasculopathy was 50% (41 cases 
with decidual vasculopathy and 41 control cases without the lesions).
Preeclampsia was defined as new onset hypertension (diastolic blood pressure of 
≥90 mmHg or systolic blood pressure of ≥140 mmHg) after 20 weeks gestational age, 
with proteinuria of ≥0.3 g/24h urine or urine protein-to-creatinine ratio of ≥0.3 g/10 mol 
creatinine. Patients’ characteristics were gathered from their medical charts (Table 1). 
For our analysis of the clinical outcome of preeclampsia, we used the highest recorded 
diastolic blood pressure as the value for blood pressure and protein-to-creatinine ratio as 
the measurement for proteinuria. Clinical parameters analyzed are listed in Table 2. The 
histological parameters are listed in Table 3.
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Histological analysis
All placenta tissues had been processed according to the hospital’s protocol for placental 
pathology. Decidual vasculopathy is not uniformly distributed in the spiral arteries. To 
correct for this potential sampling error we included cases with at least two membrane rolls, 
as the lesions are more readily found in the decidua parietalis due to the greater number of 
spiral arteries present, compared to samples of decidua basalis. Slides from the central and 
peripheral part of the placenta were included, as well as slides of any abnormalities seen on 
macroscopic analysis. All slides had been stained with Hematoxylin & Eosin. The slides had 
been analyzed by an experienced pathologist (J.B.). Decidual vasculopathy was defined as 
the finding of fibrinoid necrosis and foamy macrophage infiltration of the spiral artery vessel 
wall in decidua parietalis and/or decidua basalis (Fig. 1) [5, 6]. Underremodelled basal spiral 
arterioles were not considered to be part of the spectrum of decidual vasculopathy for the 
purposes of this study. The presence of perivascular lymphocytic cell infiltration (Fig. 2) was 
a non-mandatory secondary criterion. Infarction and hematoma formation, perivascular 
inflammatory cell infiltration, microscopic calcifications and accelerated villous maturity 
were scored dichotomously as being as present or not present. Accelerated villous maturity 
was diagnosed according to previously published criteria [21].
Statistical analysis
We used the program SPSS 16 for the statistical analysis. Cases with decidual vasculopathy 
were compared to cases without the lesions on various clinical and placental histological 
parameters, using Mann-Whitney test. Data are detailed as median and interquartile range 
(IQR) unless stated differently. P-value < 0.05 was considered significant.
RESULTS
In our analysis of demographic and background parameters we found no relation between 
the presence of decidual vasculopathy and age, BMI, smoking habits, parity, hypertensive 
obstetric history, use of antihypertensives during pregnancy or magnesium sulfate prior to 
delivery, compared to controls (Table 1).
Table 1 | Demographic and clinical background parameters of decidual vasculopathy (DV) group and 
controls.
Demographic parameters DV (n=41)a Controls (n=41)a p-value
Age (years) 30 (26-37) 30 (27-32) 0.484
BMI (kg/m2) 22 (17-25) 20 (17-22) 0.207
Use of tobacco 15% 22% 0.317
Primigravid 71% 73% 0.807
Obstetric history of PE/HELLP or GHb 33% 18% 0.566
Use of antihypertensives 66% 54% 0.263
Use of magnesium sulphate 68% 76% 0.355
a  Data are presented as median (interquartile range) or as percentages.
b  Analysis is confined to multigravid women, PE= preeclampsia, GH = gestational hypertension.
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Clinically, decidual vasculopathy was associated with higher diastolic blood pressure, 
shorter gestational age, lower birth weight and lower umbilical artery pH, compared to the 
control group. Groups did not differ with respect to urine protein-to-creatinine ratio, birth 
weight centile, APGAR scores and perinatal mortality. No differences were found between 
the groups for HELLP syndrome markers (lowest recorded platelet count and highest recor-
ded lactate dehydrogenase, aspartate transaminase and alanine transaminase) (Table 2).
Table 2 | Maternal and fetal clinical parameters of decidual vasculopathy (DV) group and controls.
Clinical parameters DV (n=41)a Controls (n=41)a p-value
Diastolic blood pressureb 110 (105-120) 108 (100-110) 0.027
Urine protein-to-creatinine ratiob 
(g/10mmol)
3.0 (0.9-10.1) 1.2 (0.3-5.0) 0.140
Platelet countc (x10*9/l) 136 (56-190) 115 (58-175) 0.409
Lactate dehydrogenaseb (U/l) 448 (327-1036) 549 (399-939) 0.232
Aspartate transaminaseb (U/l) 55 (17-138) 64 (20-356) 0.151
Alanine transaminaseb (U/l) 53 (11-162) 55 (13-317) 0.332
Gestational age (weeks+days) 29+6 (28+1-34+1) 32+2 (29+5-36+5) 0.030
Birth weight (grams) 1050 (755-1472) 1460 (875-2535) 0.030
Birth weight centile 7 (4-14) 11 (4-23) 0.128
APGAR 1 min 6 (3-8) 7 (4-8) 0.428
APGAR 5 min 8 (6-9) 9 (7-10) 0.124
Umbilical artery pH 7.20 (7.14-7.26) 7.25 (7.21-7.29) 0.012
Perinatal death:
- Intra uterine fetal death
- Neonatal death
- Late neonatal death
22%
10%
2%
10%
12%
5%
2%
5%
0.246
0.399
1.000
0.399
a  Data are presented as median (interquartile range) or as percentages.
b  Highest value recorded.
c  Lowest value recorded.
Decidual vasculopathy related to placental pathology. In the group with the decidual vascu-
lopathy we observed more accelerated villous maturity in the placenta and more peri-
vascular inflammatory cell infiltration of the spiral arteries, compared to the control group. 
Decidual vasculopathy seems to relate to hematoma formation, calcifications and lower 
placental weight, although this observation did not reach statistical significance (Table 3).
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Table 3 | Placental histological parameters of decidual vasculopathy (DV) group and controls.
Histological parameters DV (n=41)a Controls (n=41)a p-value
Placenta Weight 216 (164-270) 263 (187-365) 0.077
Perivascular inflammatory cell infiltration 100% 12% <0.0001
Accelerated villous maturity 100% 88% 0.022
Infarct formation 83% 76% 0.417
Hematoma formation 32% 15% 0.069
Microscopic calcifications 22% 7% 0.062
a Data are presented as median (interquartile range) or as percentages.
DISCUSSION
The aim of our study was to examine the association of decidual vasculopathy with the 
severity of disease, fetal and neonatal outcome and occurrence of placental pathology in 
patients with preeclampsia. In our analysis of maternal outcome, we observed that cases 
with decidual vasculopathy had higher diastolic blood pressure. In neonatal outcome 
parameters, decidual vasculopathy related to a shorter gestational age at birth, lower birth 
weight and lower umbilical artery pH. Our findings would support the hypothesis of a worse 
outcome for preeclamptic patients with decidual vasculopathy, with both maternal and fetal 
factors being worse compared to the preeclamptic patients without these lesions. It needs 
to be noted here that cases were not matched for gestational age (as this was one of our 
outcome parameters), which is a potential confounding factor for neonatal parameters 
such as birth weight. Our study also showed that decidual vasculopathy was associated 
with more pathological placental findings. There was more maternal perivascular 
inflammatory cell infiltration, confirming this as a minor feature of decidual vasculopathy. 
Additionally, there was more downstream accelerated villous maturity and possibly more 
hematoma formation, more calcifications and lower placental weight in the group with 
decidual vasculopathy.
The histological changes in maternal spiral arteries characteristic of decidual vasculopathy 
have been encountered in various clinical conditions. The occurrence of similar vascular 
lesions in physiologically modified spiral arteries in normal pregnancy is debatable. Fibrinoid 
material deposition in vessel walls, which is a hallmark of physiologically modified spiral 
arteries, is also present, albeit in more extensive form (fibrinoid necrosis) in decidual 
vasculopathy. In addition, the vessels in decidual vasculopathy show marked foam cell 
infiltration of the wall and loss of vascular smooth muscle cells. It is generally accepted 
that decidual vasculopathy occurs mainly in spiral arteries that have failed to undergo 
physiological modification in early pregnancy. The relation of decidual vasculopathy to 
lack of physiological changes in spiral arteries, and to their putative underlying etiology, 
the inadequate trophoblast invasion, is still unclear. Similar pathological features have 
also been described in myometrial segments of spiral arteries, where the difference in 
spiral artery modification between normotensive and preeclamptic pregnancies is most 
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evident [22, 23]. On the other hand, it is important to note that decidual vasculopathy also 
occurs in vessels of the decidua parietalis where invading trophoblasts are generally 
lacking [24]. It is tempting to speculate that decidual vasculopathy may be a consequence 
of the hyperinflammatory state of preeclampsia, damaging the vessel wall via activated 
macrophages in both decidua basalis and parietalis, irrespective of trophoblast-mediated 
physiological modification [25].
The time course as well as the sequence of events in the development of decidual 
vasculopathy is difficult to establish. Our data may suggest that accelerated villous maturity 
is the earliest histological manifestation of pathology in preeclampsia, based on the fact 
that it has the highest prevalence of the histologic features examined in both decidual 
vasculopathy and control groups. In a proportion of preeclamptic patients, additional 
pathological lesions develop, namely, decidual vasculopathy, infarctions, hematoma and 
calcifications. In decidual vasculopathy, perivascular inflammatory cell infiltration and 
fibrinoid necrosis appear to be early manifestations of decidual vasculopathy, with foam 
cell infiltration and thrombosis representing later stages of the same disease process. In 
this line of reasoning, the pathological process underlying decidual vasculopathy may be 
initiated by an unbalanced placental oxygen deliverance leading to placental damage and 
with it systemic maternal immunological reaction to shed semi-allogenous trophoblast 
cells. Supporting this is the fact that deposits of immunoglobulins and complement factor 
3 have been found in the arteries affected by decidual vasculopathy [4]. Additionally, it 
has been noted that the morphology of lesions in the tissue of rejected renal transplants 
is remarkably similar to that of decidual vasculopathy [4]. The inflammatory response 
manifested in the spiral arteries results into perivasculitis and increased endothelial 
permeability, causing deposition of coagulation factors within the vessel wall, and thus 
fibrinoid necrosis. Cell damage caused by the inflammatory response then attracts 
macrophages, which transform into foam cells after phagocytosis of cell remnants. 
Although foam cells were initially thought of as early lesions [8, 26], more recent studies 
agree they represent a later stage [3]. In further support of this is work done by Katabuchi 
et al. (2003), who found evidence of cell membrane remnants within the cytoplasm of foam 
cells seen in decidual vasculopathy [27].
To understand the impact of decidual vasculopathy on the severity of preeclampsia, 
a mechanism needs to be postulated which fits into the general pathophysiology of 
the disease. Recently, the central dogma of “placenta hypoxia” as the key process due 
to unmodified spiral arteries has been challenged by Burton et al. (2009) [28]. They 
hypothesized that the lack of spiral artery modification would first result in high-speed 
turbulent damaging blood flow in the placenta rather than directly resulting in chronic 
hypoxia and that additional pathology such as decidual vasculopathy or thrombosis 
are likely to further reduce vessel caliber thereby reducing intervillous blood flow and, 
consequently, oxygen delivery. This hypothesis could also explain the mechanism by 
which decidual vasculopathy is associated with increased placental villous lesions, such as 
bleeding and infarctions [19, 20].
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In order to provide a better insight into the role of these intriguing lesions in the pathology of 
preeclampsia, a more detailed analysis is needed regarding their location (decidua basalis 
or parietalis), their surrounding environment (extravillous trophoblasts, uterine NK cells, 
decidual extracellular matrix), their etiology (immunological markers), and the relevance of 
each morphological feature (fibrinoid necrosis, foam and inflammatory cell infiltration and 
thrombosis) to clinical and histological parameters of disease severity.
Studying decidual vasculopathy could unravel certain mechanisms to improve our 
understanding of preeclampsia, and possibly identify a specific subgroup of patients with 
higher risks from the disease who could benefit from targeted screening or treatment.
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ABSTRACT
Objective
In a proportion of patients with preeclampsia, unremodeled spiral arteries develop 
additional pathological changes, termed decidual vasculopathy (DV), or acute atherosis. 
DV has been correlated to adverse clinical outcome and increased placental pathology. 
However, it was unclear whether these effects pertained to individual features of DV.
Methods
We performed a reanalysis of placental samples from preeclamptic pregnancies (n= 
76), recording the number of vessels with DV, their location in the decidua and their 
morphological features. Results were correlated with clinical and placental parameters, 
using Spearman’s rho test. P-value < 0.05 was considered significant.
Results
Total number of vessels with DV (totalDV) correlated with higher diastolic blood pressure, 
higher urine protein-to-creatinine ratio, shorter gestational age, lower birth weight, 5 min 
APGAR score and umbilical artery pH, and with increased accelerated villous maturity, 
infarction and hematoma formation, but not with HELLP syndrome markers. Additionally, 
there was a striking correlation of increased perinatal mortality with the number of vessels 
located in the decidua basalis (DVbas), and with vessels showing DV with thrombosis 
(DVthrom). Other morphological features, such as foam cell infiltration, did not increase 
correlation strength.
Discussion 
In our study of preeclamptic placental samples, totalDV related to worse clinical outcome 
and increased placental pathology. Moreover, DVbas and DVthrom related to perinatal 
death. DV could be a manifestation of an underlying (vascular) pathology, increasing the 
risk of adverse pregnancy outcome. 
Conclusions
In preeclampsia, totalDV, DVbas and DVthrom correlated with increased placental pathology 
and adverse maternal and fetal outcome, most relevantly with perinatal mortality.
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INTRODUCTION
Preeclampsia is a hypertensive disease of gestation, occurring in 2-8% of pregnancies 
[1]. It is diagnosed by (new onset) hypertension and significant proteinuria after 20 
weeks gestational age [2]. The complications of preeclampsia are severe, and it carries a 
significant part of the burden of maternal and perinatal mortality worldwide [1, 3]. Although 
its etiology has not yet been unraveled, a common pathway in the early preclinical stages 
towards preeclampsia is thought to be dysfunctional uteroplacental blood flow [4]. In 
patients with preeclampsia, placentation is mostly defective, demonstrated by a lack 
of the physiological adaptation of spiral arteries to pregnancy [4]. The relatively narrow, 
vasoreactive vessels negatively affect uteroplacental circulation, leading to down-stream 
placental pathology [4]. Factors released by the affected placenta enter the systemic 
circulation, evoking a reaction from the maternal system, leading to endothelial dysfunction 
and, eventually, clinical manifestations of preeclampsia [4]. 
In a subset of patients with preeclampsia, spiral arteries undergo additional pathological 
changes, termed decidual vasculopathy (DV), or acute atherosis. The etiology of DV is 
unknown. These pathological lesions are nearly exclusively observed in spiral arteries 
that have failed to undergo the physiological adaptation of pregnancy. The definition of 
DV has been the subject of debate [5, 6]. Generally, DV is defined as the presence of foam 
cells and fibrinoid necrosis within the vessel wall (Fig. 1) [7, 8]. Perivascular inflammatory 
cell infiltration, thrombosis and media hypertrophy (also called hypertrophic DV) are as-
sociated pathological features [7, 8]. The prevalence of DV varies greatly in literature, with 
percentages ranging from 4 to 75% [9-14], arguably due to differences in the definition of the 
lesions and whether tissue sections from both decidua basalis and parietalis were included.
As the lesions of DV are observed in the proposed primary location of the disease 
process of preeclampsia, the spiral arteries, it is possible that they further aggravate 
its pathophysiology. This raises the question whether the lesions also relate to disease 
severity. Khong et al. (1987) noted that in preeclampsia, DV related to shorter gestational 
age at birth, but not to proteinuria, hyper-tension or to other perinatal outcome parameters 
[11]. Others did observe an association of the lesions with severity of disease [12], as well 
as with lower birth weight [14, 15]. Additionally, DV related to placental infarctions [16] 
and hematomas [17]. We recently observed an association of DV with adverse clinical 
outcome and placental pathology in preeclampsia [18]. Clinically, DV related to higher 
diastolic blood pressure, shorter gestational age, lower birth weight and lower umbilical 
artery pH. Histologically, DV related to more accelerated villous maturity and perivascular 
inflammatory cell infiltration [18]. 
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Figure 1 | Decidual vasculopathy in decidua basalis with fibrinoid necrosis (star) and foam cells 
(arrow) (Hematoxylin & Eosin 100x). 
Source: Radboud university medical center.
It was therefore obvious from available literature and results of our previous study that DV 
was associated with adverse clinical outcome and placenta pathology in preeclampsia. 
However, the underlying pathophysiology of the lesions and contribution of their individual 
features to this process is unclear. Theoretically, DV could further impede spiral artery blood 
flow into the intervillous space, and, subsequently, worsen the pathological changes in the 
placenta [19]. Thus, factors, such as the number of vessels affected and their location in 
the decidua of placental bed or underlying the fetal membranes may play a role. Individual 
morphological features of the lesions, such as perivascular inflammatory infiltration and 
thrombosis, could further indicate a more advanced form of disease and might possibly 
elucidate the chronological order in which DV lesions develop.
In this study, we tested the hypothesis that in placentas from preeclamptic pregnancies, 
the number of vessels affected by DV, their location in the decidua and the morphological 
features of the lesions correlate to adverse clinical parameters, worse perinatal outcome 
and increased frequency of other placental pathological lesions.
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METHODS
In this retrospective study, we performed a histological reanalysis of placental samples in 
order to record the number of vessels affected by DV, their location in decidua parietalis 
and/or decidua basalis, and their individual morphological features. These characteristics 
of DV were thereafter correlated with maternal and perinatal outcomes as well as other 
features in the placental pathology report.
Population selection and clinical data
Clinical data and placental histological samples were gathered from patients admitted 
with preeclampsia at the tertiary referral center Radboud university medical center, during 
the years 1995-2000. Based on availability, an initial number of 107 cases were selected. 
Clinical and placental histological data of these cases were used in our earlier study on 
DV and clinical outcome in preeclampsia [18]. Exclusion criteria were incomplete data 
or multiple pregnancy (n= 25), and un-availability of placental samples for histological 
reanalysis (n= 6). Preeclampsia was defined as (new onset) hypertension (systolic blood 
pressure of ≥140 mmHg or diastolic blood pressure of ≥90 mmHg) with proteinuria of ≥0.3 
g/24 h urine or urine protein-to-creatinine ratio of ≥0.3 g/10 mol, after 20 weeks gestational 
age [2]. Clinical parameters were gathered from patients’ medical charts. Highest recorded 
diastolic blood pressure was used as the value for blood pressure and protein-to-creatinine 
ratio as the measurement for proteinuria.
Histological reanalysis
Microscopic reanalysis of all placental samples was performed independently by J.B and 
D.S. using a revised scoring list developed for this study. Mismatches in scoring between 
the examiners were reviewed and discussed to reach a consensus. Placental tissues had 
previously been macroscopically analyzed according to the hospital’s standard protocol for 
placental pathology in preeclampsia. Slides from membrane rolls, central and peripheral 
part of the placenta had been included, as well as slides from any abnormalities seen 
during macroscopic analysis. All slides had been stained with Hematoxylin & Eosin. For our 
reanalysis, all slides were re-examined, using both low and high power magnification. 
In order to include all vessels affected by DV, we chose to define the lesions by the 
presence of fibrinoid necrosis, which in more recent literature has been described as the 
earliest characteristic feature of DV [5]. Fibrinoid necrosis was identified as the presence 
of a complete or partial fibrin ring in unremodeled spiral arteries (Fig. 1). We recorded the 
total number of spiral arteries with DV (i.e. fibrinoid necrosis, with or without additional 
features) and their location in decidua basalis and/or parietalis. In order to study different 
types or stages of the DV lesions we also recorded the number of vessels with DV that 
showed additional morphological features (foam cells, perivascular lymfocytic cells, and 
thrombosis). Lastly, the number of spiral arteries with perivascular lymfocytic cells without 
fibrinoid necrosis and the number of vessels with media hypertrophy (Fig. 2) were recorded.
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Figure 2 | A. Decidual vasculopathy in decidua parietalis with hypertrophic media (insert) and 
fibrinoid necrosis (arrow) (Hematoxylin & Eosin 100x). B. Hypertrophic media (Hematoxylin & 
Eosin 200x). 
Source: Radboud university medical center.
To correct for potential sampling bias, cases without sufficient membrane roll samples 
were excluded. As the lesions are most readily observed in the decidua parietalis, a 
sufficient amount of membrane tissue is to be included for microscopic analysis. In order 
to quantify the amount of decidual tissue per case, total length of decidua basalis and 
mean diameter of membrane rolls were measured, and number of windings per membrane 
roll recorded. Macroscopic parameters of placental weight, placental weight centile, 
retroplacental and/or marginal hematoma and infarction formation were not reanalyzed, 
as original complete placental tissue was not available. In order to quantify their clinical 
relevance, macroscopic hematoma and infarction formation were scored as percentages 
of placental surface. Accelerated villous maturity and microscopic calcifications were 
described as present or absent. Accelerated villous maturity was diagnosed according to 
previously published criteria [20]. Median number of missing values of outcome parameters 
was 3, with a minimum of 0 and a maximum of 17.
Statistical analysis
SPSS 20 was used for statistical analyses. Patient and placental sample characteristics 
of cases with DV were compared to cases without the lesions using Mann-Whitney test 
for continuous data and Pearson’s chi square or Fisher’s exact test (where appropriate) 
for categorical data. Number of vessels with DV, number of vessels with DV in decidua 
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basalis and parietalis, and number of vessels with DV and foam cells, perivascular 
inflammatory cells and thrombosis were tested for correlation with maternal and perinatal 
clinical outcome and placental histological parameters, using Spearman’s rho test for both 
continuous and categorical data. P-value < 0.05 was considered significant.
RESULTS
In all 76 cases included in this study, unmodified spiral arteries were abundant throughout 
the decidua. The DV group (n= 45) was comparable to the control group (n= 31) in terms of 
placental samples examined and patient characteristics, except for a higher percentage of 
first trimester hypertension in the DV group (Table 1).
Table 1 | Patient and placental sample characteristics: cases with decidual vasculopathy (DV) versus 
cases without the lesions (control), in women with preeclampsia.
Patient characteristics DV (n=45) Control (n=31) p-values
Age (years) 30 (26-36) 31 (29-32) 0.804c
BMI (kg/m2) 21 (17-25) 20 (17-22) 0.144c
Race 0.786d
Caucasian 91% 97%  
African 4% 0%  
Other 5% 3%  
First trimester hypertensiona 20% 3% 0.041d
History of PE/HELLP or GHb 7% 3% 0.641d
Multiparous 16% 4% 0.131d
Fetal gender female 67% 48% 0.111e
Use of anti-hypertensives 67% 52% 0.187e
Use of magnesium sulfate 76% 77% 0.912e
Placental sample characteristics  
Number of windings (per membrane roll) 5 (5-6) 5 (4-7) 0.608c
Diameter membrane rolls (mm) 15 (12-17) 14 (12-16) 0.383c
Length decidua basalis (mm) 50 (31-65) 40 (32-56) 0.357c
a  Hypertension diagnosed before 20 weeks gestational age.
b  Obstetric history of preeclampsia/HELLP and/or gestational hypertension.
c  Mann Whitney test, data presented in median and interquartile range.
d  Fisher’s Exact Test, data presented in percentages.
e  Pearson’s Chi-Square, data presented in percentages.
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Various types of spiral artery lesions were observed (Table 2). DV, defined in this study as 
vessels with fibrinoid necrosis, was observed in 59%, while vessels with both DV and foam 
cell infiltration and vessels with DV and perivascular lymphocyte infiltration were observed 
in 54% and 40% of cases, respectively. We did not encounter foam cell infiltration in vessels 
without evidence of DV. Vessels with DV and thrombosis were present in 25% of cases. 
Proposed precursor DV lesions, namely, perivascular lymfocytic infiltration without DV and 
vessels with only hypertrophic media, were observed in 57% and 37% of cases, respectively. 
In the group showing DV changes, 33% of cases showed DV in decidua parietalis only, 
25% in decidua basalis only and 42% in both decidua parietalis and basalis. The number of 
vessels per case was higher in decidua parietalis than in decidua basalis.
There was a trend for a worse clinical outcome parallel with the increase in number of 
vessels affected by DV and with the increase in vessels with DV and associated lesions. 
Most importantly, both the number of vessels with DV in the decidua basalis (DVbas), as 
well as the number of vessels with DV and thrombosis (DVthrom) correlated with perinatal 
death (Table 3).
In addition, the total number of vessels with DV (totalDV) correlated with higher diastolic 
blood pressure and urine protein-to-creatinine ratio, shorter gestational age at birth, and 
with lower birth weight, 5 min APGAR score and umbilical artery pH (Table 3). In placental 
parameters, totalDV correlated with an increased amount of accelerated villous maturity, 
infarction and hematoma formation (Table 3). There was no correlation between totalDV 
and HELLP syndrome markers (platelets, lactate dehydrogenase, aspartate transaminase, 
alanine transaminase), birth weight centile, perinatal death, placental weight, placental 
weight centile, or microscopic calcifications (Table 3).
Table 2 | Frequency of different types of spiral artery lesions in the decidua from women with 
preeclampsia.
Histological parameters Percentage Number of vessels b
Fibrinoid necrosis (FN) 59% (n=45)a 6 (3-12)
Fibrinoid necrosis with:
 ͳ Foam cell infiltration
 ͳ Perivascular lymfocytic infiltration
 ͳ Thrombosis
54% (n=40)a
40% (n=30)a
25% (n=19)a
3 (2-5)
4 (2-6)
2 (1-3)
Perivascular lymfocytic infiltration  
(no fibrinoid necrosis)
57% (n=41)a 8 (4-10)
Hypertrophic media 37% (n=28)a 7 (2-15)
Location:  
 ͳ Decidua parietalis only
 ͳ Decidua basalis only
 ͳ Decidua basalis and parietalis
33% (n=15)c
25% (n=11)c
42% (n=19)c
3 (3-15)
3 (1-4)
10 (6-14)
a  Data are expressed as percentage of the total number of cases (n=76).
b  Number of vessels is expressed as median and interquartile range.
c  Data are expressed no of cases within DV (fibrinoid necrosis) group (n=45).
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In our analysis of placental bed lesions, we observed that, aside from an association 
with perinatal death, DVbas also correlated with other clinical parameters, but not with 
placental pathology (Table 3). DV in the decidua parietalis (weakly) correlated with outcome 
parameters, namely, higher urine protein-to-creatinine ratio (r=+0.298, p=0.014), lower 
aspartate transaminase (r=- 0.250, p=0.030), lower umbilical artery pH (r=- 0.394, p=0.001), 
increased infarct (r=+0.257, p=0.034) and hematoma (r=+0.332, p=0.007) formation. 
In morphological features of DV, DVthrom correlated most strongly with clinical and placen-
tal outcome, whereas number of vessels of DV with foam cells and of DV with inflammatory 
cells related to a modest number of parameters (Table 3). Proposed component lesions of 
DV showed the weakest correlation with disease outcome, with vessels with hypertrophic 
media relating to shorter gestational age (r= -0.277, p=0.016), birth weight in grams (r= 
-0.260, p=0.023) and umbilical artery pH (r=-0.348, p=0.005) and perivascular inflammatory 
cell infiltration without DV to umbilical artery pH only (r=-0.251, p=0.044).
DISCUSSION
The finding of DV in placental samples from preeclamptic pregnancies has intrigued 
both pathologists and clinicians since its description by Hertig et al. (1945) [21]. In a 
recent article, we showed a correlation between DV and adverse perinatal outcome and 
additional placental pathology [18]. However, it remained unclear from our data how these 
lesions contribute to a worse clinical outcome. In this study we performed a more detailed 
analysis of placental samples from the same preeclamptic population in order to study 
the correlation of the number of vessels with DV, their location in the decidua and their 
morphological features, with clinical outcome and placental pathology.
TotalDV correlated with higher diastolic blood pressure and urine protein-to-creatinine 
ratio, shorter gestational age at birth, and lower birth weight, 5 min APGAR score and 
umbilical artery pH. In addition, totalDV correlated with a higher amount of hematoma and 
infarction formation. Our findings support the hypothesis that DV is a progressive entity 
within preeclampsia; the more vessels are affected, the wider the damage to the overlying 
placental villi and consequently the worse the clinical picture for both fetus and mother.
Regarding the location of lesions, it is interesting to note that the correlation between the 
number of vessels affected by DV and clinical outcome (but not placenta pathology) was 
stronger when focusing our attention on lesions found in the decidua basalis. The finding 
that DV in the decidua basalis, especially in combination with thrombosis, correlated to 
perinatal death, is striking. Previous literature has noted an association between placental 
pathology - specifically infarction - and perinatal mortality [22]. In this study placental 
infarction did not correlate with perinatal death (r=+0.175, p= 0.354), suggesting this did not 
have a confounding effect our results. These observations suggest that the development of 
DV has a more profound effect on placental circulation than previously thought [5].  
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Although DV was found in both segments of the decidua (basalis and parietalis), it is 
interesting to view this correlation with severity from the perspective of extravillous 
trophoblast invasion. In normal pregnancy, extravillous trophoblast invade spiral arteries in 
the decidua basalis (but not in the decidua parietalis) converting them into low-resistance 
vessels. In preeclampsia, deficient trophoblast invasion is implicated in the lack of spiral 
artery modification in the decidua basalis [23]. These non-invasive trophoblast cells could 
interact with various local mediators, leading to leukocytic cell infiltration and fibrinoid 
necrosis characteristic of DV. 
There was a higher prevalence of preexisting hypertension in the DV group, compared 
to controls. Preexisting hypertension was defined as hypertension diagnosed before 20 
weeks gestational age. It is therefore unclear whether this signifies a preconceptional 
difference between the groups or a sign of early hemodynamic maladaptation to pregnancy, 
increasing the risk of developing DV.
Aside from DV with thrombosis, individual morphological features did not add to the 
correlation strength with outcome parameters. However, studying these features separately 
could help recreate the pathophysiological timeline of these lesions.  Based on prevalence, 
both fibrinoid necrosis and perivascular inflammatory cells without fibrinoid deposition are 
candidates for the early stage of DV, as they were most frequently observed. Thrombosis 
could be a late phenomenon, being a rare lesion.
It would be tempting to speculate on how DV fits into the pathophysiology of preeclampsia. 
DV-like lesions have been described in curetted endometrium of first trimester pregnancies 
[24, 25], suggesting that they can be a phenomenon of early pregnancy.  On the one 
hand, the fact that the lesions are observed only in a proportion of cases who develop 
preeclampsia, as well as in other diseases of pregnancy [5, 6, 10, 26, 27], argues against DV 
being part of the etiology of the disease and suggests rather that the lesions play a role in a 
subtype of the disease. On the other hand, it can be hypothesized that these diseases share 
a common underlying pathology (i.e. vascular or immunological dysfunction) predisposing 
patients to adverse pregnancy outcomes, with the eventual phenotype of the disease 
depending on additional factors such as fetal genetic makeup.  
Both immunological and atherosclerosis-related processes have been suggested as the 
etiology of DV, mostly because of the similarities on microscopic examination between 
the lesions and those observed in atherosclerotic plaques and allograft transplantation 
rejections [6, 28]. Deposits of immunoglobulins and complement factor 3 have been 
demonstrated in DV lesions [6]. It would be interesting to explore the relationship between 
these lesions and their proposed etiology in greater detail. Studies could focus on 
immunohistochemical analysis of affected spiral arteries and the placental bed, as well as 
explore the relationship between the lesions and cardiovascular risk factors. 
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In conclusion, in an effort to elucidate the impact of DV on preeclamptic pregnancies, we 
have shown that the number of vessels with DV, particularly when located in the placental 
bed or accompanied by thrombosis, relate to worse clinical outcome, most importantly to 
increased perinatal mortality. As we study the clinical relevance of the lesions, questions 
arise on the etiology of the lesions and how they relate to specific pathophysiological pro-
cesses described in preeclampsia, such as reduced trophoblast invasion and differentiation.
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ABSTRACT
Objective
A subgroup of preeclamptic women has spiral artery lesions termed decidual vasculopathy 
(DV) which relate to worse clinical outcome. We aimed to determine whether a history of 
preeclampsia with DV is associated with adverse overall and future pregnancy outcome, 
including increased recurrence risk of hypertensive diseases of pregnancy. 
Methods 
Via posted survey women with preeclampsia and DV (DV positive) in the index pregnancy 
were compared to those without the lesions (DV negative) on overall and future pregnancy 
outcome.
Results
DV positive cases showed a higher incidence of chronic hypertension both 
preconceptionally and at time of survey, adjusted odds ratio 4.8 (2.0-11.9). The DV positive 
group had a higher overall incidence of pregnancies with gestational hypertension (22% vs 
13%, p=0.04), preterm birth (59% vs 45%, p=0.02), and a lower birth weight centile (30 vs 39, 
p=0.02). There was no difference in outcome of future pregnancies, irrespective of the use 
of prophylactic aspirin.
Conclusion 
Women with DV associated preeclampsia have a higher overall incidence of adverse 
obstetric outcome and of chronic hypertension, indicating an underlying vascular 
pathology, putting them at risk for pregnancy and cardiovascular complications. These 
women constitute a target group for counselling, monitoring and possibly lifestyle or 
pharmacological interventions.
209991-L-bw-stevens
45
Hypertensive disorders after preeclampsia with decidual vasculopathy
4
INTRODUCTION 
Normal placentation is a prerequisite for a successful pregnancy outcome. This 
process encompasses complex interaction between invading fetal cells (interstitial 
and endovascular extravillous trophoblast) and fostering maternal tissue (decidua and 
myometrium). The placenta plays a central role in the development of preeclampsia (PE) 
and associated neonatal morbidity, including fetal growth restriction and preterm delivery 
[1-2]. It is generally accepted that PE originates at the placental bed, from defective 
extravillous trophoblast invasion and failure of physiological modification of maternal 
spiral arteries[3]. This is thought to lead to the second stage of the disease, characterized 
by abnormal placental circulation and ensuing oxidative stress, which stimulates 
syncytiotrophoblasts to release micro- or nanoparticles into the intervillous space [3]. These 
trophoblast-specific particles enter the maternal circulation and are thought to cause the 
wide-spread secondary endothelial activation characteristic of PE [3].
In a proportion of patients with PE, unmodified spiral arteries undergo additional pathologi-
cal changes, termed decidual vasculopathy (DV) or acute atherosis [4]. DV is characterized 
by fibrinoid necrosis and infiltration of foam cells within the vessel walls, with minor fea-
tures of perivascular inflammatory cell infiltration, medial hypertrophy and thrombosis [5, 6]. 
DV potentially aggravates the dysfunctional utero-placental flow and subsequently placental 
and clinical disease [7]. DV has been related to adverse maternal and neonatal outcome and 
a higher incidence of placental pathology in preeclamptic pregnancies. The lesions were as-
sociated clinically with a higher diastolic blood pressure, shorter gestational age, lower birth 
weight and lower umbilical artery pH [4.8-10]. Histologically, DV has been related to a higher 
incidence of accelerated villous maturity, placental infarctions and hematomas [8, 11, 12]. 
Moreover, the impact of DV on clinical severity and neonatal outcome in PE is related to the 
number and location of affected spiral arteries [6].
A history of PE is associated with recurrent adverse pregnancy outcome in future 
pregnancies, such as maternal gestational hypertensive disease and its sequellae on the 
one hand, and stillbirth, placental abruption, preterm delivery and small for gestational age 
births on the other [13]. The recurrence risk is correlates with the severity of PE in the index 
pregnancy and the gestational age at onset of disease [14, 15]. There is no data on how 
DV relates to compound obstetric outcome and recurrence risk of hypertensive diseases 
of pregnancy (HDP). The aim of this study is to determine whether the presence of DV 
during the preeclamptic index pregnancy is associated with an increased overall and future 
incidence of adverse pregnancy outcome, mainly hypertensive diseases of pregnancy.
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METHODS
Our study was conducted retrospectively via posted survey. Women with PE with DV (DV 
positive) were compared to cases without the lesions in the preeclamptic index pregnancy 
(DV negative) on outcome parameters of overall and future obstetric outcome, including 
recurrence risk of PE and HDP. The study was reviewed by the medical ethics comity Arn-
hem-Nijmegen (METC), and assessed as not mandatory to the World Health Organization 
enactment (METC numbers 2011/323 and 2012/411, on the 29th of July 2011 and the 6th 
of September 2012 respectively). This study was conducted in two phases. Women with 
PE or HELLP syndrome, who delivered at Radboud university medical center between the 
years 1995-2000 were selected based on availability of clinical data and placental samples. 
Because not enough cases could be included in the initial study group, a second group was 
contacted consisting in women who delivered between the years 2001-2010. Multiple preg-
nancies were excluded. A total of 260 patients were selected. Current contact information 
was obtained for 161 patients. 144 patients gave informed consent. Eventually 119 ques-
tionnaires were returned (response rate 83%). The prevalence of DV was 46% (DV positive 
n=55, DV negative n=64). All patients gave permission to use their records for research.
PE was defined as hypertension (systolic blood pressure of ≥140 mmHg and/or diastolic 
blood pressure of ≥90 mmHg) and substantial proteinuria (≥0.3 g in 24 h or protein-to-
creatinine ratio of ≥0.3 g/10 mmol creatinine) at or after 20 weeks gestational age [16]. 
HELLP-syndrome was defined as platelets <100x109/L, aspartate aminotransferase (ASAT) 
>70 U/L, and lactic acid dehydrogenase (LDH) >600 U/L. Intrauterine growth restriction 
(IUGR) is defined as neonatal birth weight below the 10th centile for gestational age as 
defined by data from the Perinatal Registration Netherlands.  HDP was defined as PE, 
HELLP-syndrome or gestational hypertension (hypertension without proteinuria after 20 
weeks gestational age). 
Histological analysis
Pathological analysis had been performed on placental samples. DV was defined as 
fibrinoid necrosis and foam cell infiltration of the spiral arteries (Figure 1). Perivascular 
inflammatory cell infiltration, medial hypertrophy and thrombosis were non mandatory 
secondary features. All macroscopic histological analyses of placental tissue had been 
performed at the Radboud university medical center by experienced pathologists according 
to standard hospital protocol for PE. In order to insure an accurate prevalence of DV, all 
microscopic samples were reanalysed by a pathologist experienced with DV (J.B.) who was 
unaware of clinical parameters. Additionally, as DV is more readily identified in de decidua 
parietalis, all cases were required to include two or more membrane rolls.
Survey
The survey was divided in patient background variables (chronic hypertension, auto-
immune disease and diabetes in patients’ history, and smoking, coffee and alcohol habits), 
family history of PE, obstetric history (pregnancy outcome, location, gestational age, birth 
weight, neonatal outcome) and specific questions concerning preeclamptic pregnancies 
(time of unset, symptoms and treatment). 
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Figure 1 | Decidual vasculopathy in decidua parietalis with fibrinoid necrosis, foam cells and 
perivascular inflammatory cell infiltration (Haematoxylin & eosin 100x).  
Source: Radboud university medical center.
Statistical analysis
Analysis of significance was performed using chi-square test, Fisher’s extract test and 
binary logistic regression for categorical data, Student’s t-tests for parametric parameters, 
and Mann-Whitney test for non-parametric parameters with SPSS 18. P-value < 0.05 was 
considered significant.
RESULTS 
In our analysis of population characteristics (Table 1) the prevalence of chronic 
hypertension was significantly higher in the DV positive group both prior to index 
pregnancy as well as at the time of survey. There was no difference between the groups 
for parameters of history of diabetes, auto-immune disease or kidney disease, familial 
history of PE, or use of tobacco, alcohol and coffee. Background analysis showed no 
significant difference in age, time of follow up, percentage of multiparous women, total 
number of pregnancies, number of pregnancies per woman, number of births and number 
of miscarriages. 
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Table 1 | Patient characteristics of women with a history of preeclampsia/HELLP (PE) with decidual 
vasculopathy (DV positive) versus women with a history of PE without the lesions (DV negative).
Patient and pregnancy characteristics DV positive 
(n=55)
DV negative 
(n=64)
P-value
Age at time of measurement (years) 40 (6) 40 (6) 0.73d
Age at index pregnancy (years) 31 (4) 30 (4) 0.31d
Follow up time (years) 9 (4) 10 (5) 0.65d
Multiparous (%) 75 76 0.92e
Total number of pregnancies
 ͳ Birth (%)a
 ͳ Miscarriage (%)b
 ͳ Other (%)c
150
80
18
2
167
79
19
2
1.00f
Number of pregnancies (per case) 2 (1) 2 (1) 0.86f
Comorbidity (n=55) (n=64)
Chr. hypertension (%) (at time of measurement) 58 20 <0.0001e
Chr. hypertension (%) (prior to index pregnancy) 20 5 0.01e
Diabetes mellitus (%) 2 3 0.67e
History of gestational diabetes (%) 4 6 0.54e
Auto-immune disease (%) 6 8 0.66e
Kidney disease (%) 2 5 0.41e
Familial history of PE/HELLP (n=55) (n=64)
Maternal (%) 27 22 0.50e
Paternal (%) 5 2 0.24e
Habits (n=55) (n=64)
Smoking (%) 14 7 0.33e
Alcohol consumption (%) 22 26 0.68e
Coffee consumption (%) 70 54 0.12e
a  Delivery after 15 weeks of gestational age
b  Natural delivery before 15 weeks of gestation 
c  Any other form of pregnancy (molar pregnancy, ectopic pregnancy, provoked abortion) 
d  Independent samples t-test: mean (standard deviation)
e  Chi-square test
f  Mann-Whitney test: median (interquartile range)
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Outcome parameters are shown in Table 2. The overall incidence of pregnancies 
complicated by gestational hypertension and preterm births (gestational age less than 34 
weeks) was significantly higher in the DV positive group. Most of the preterm deliveries 
where iatrogenic because of PE or gestational hypertension (DV positive 90% vs DV 
negative 93%, p=0.75). Additionally, both birth weight in grams and birth weight corrected 
for gestational age of neonates in DV positive group were significantly lower, although the 
percentage of cases with IUGR (defined as birth weight <10th centile) was comparable. 
There was no significant difference between groups in number of women with recurrent 
PE or HDP, or in the number of recurrences per woman. There was no difference between 
groups for number of pregnancies, number of pregnancies complicated by PE, number of 
births, number of miscarriages, gestational age at birth, neonatal gender or prophylactic 
use of low dose aspirin. Results for all of the pregnancy outcome parameters showed no 
significant differences between the groups when analysing pregnancy outcome after index 
pregnancy only.
Secondary analysis
The increased risk of chronic hypertension at time of survey remained significant after 
correction for chronic hypertension prior to index pregnancy with an adjusted odds ratio of  
4.8 (95% CI 2.0-11.9). 
In our secondary analysis of the pregnancies in women who used prophylactic low dose 
aspirin we found a significant overall reduction in the incidence of HDP for both the DV 
positive group (aspirin+ 66% vs  aspirin- 87%, p=0.02) and DV negative group (aspirin+ 64% 
vs aspirin- 83%, p=0.02). This difference was not significant when analysing pregnancies 
after index case only for neither the DV positive group (aspirin+ 57% vs aspirin- 72%, p=0.30) 
nor the DV negative group (aspirin+ 54% vs aspirin- 45%, p=0.57).  When selecting only the 
pregnancies in which low dose aspirin was used, there was no difference in de incidence of 
HDP between the DV positive and DV negative group for all pregnancies (DV+ 66% vs DV- 
64%, p=0.86) or  pregnancies after index case (DV+ 57% vs DV 54%, p=0.85). 
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Table 2 | Outcome parameters of women with a history of preeclampsia/HELLP (PE) with decidual 
vasculopathy (DV positive) versus women with a history of PE without the lesions (DV negative). 
Overall pregnancy outcomea DV positive 
(n=120)
DV negative 
(n=132)
P-value
Preeclamptic/HELLP pregnancies (%) 58 64 0.50g
Pregnancies with gestational hypertension (%) 22 13 0.04g
Pregnancies with hypertensive disease of pregnancy (%) 80 77 0.58g
Neonatal gender female / male (%) 53 / 47 52 / 48 0.77g
Prophylactic use of low dose aspirin (%) 31 29 0.75g
Gestational age at birth (days) 239 (36) 244  (35) 0.19h
Preterm birth (%)b 59 45 0.02g
Birth weight (grams) 2027 (1127) 2326 (1203) 0.04h
Birth weight (centile) 30 (40) 39 (46) 0.02h
IUGR (%)c 22 24 0.72g
Neonatal mortality (%)d 13 8 0.20g
Future pregnancy outcomee (n=44) (n=57)
Preeclamptic/HELLP pregnancies (%) 24 21 0.52g
Pregnancies with gestational hypertension (%) 40 28 0.20g
Pregnancies with hypertensive disease of pregnancy (%) 64 49 0.12g
Neonatal gender female / male (%) 52 / 48 53 / 47 0.90g
Prophylactic use of low dose aspirin (%) 56 52 0.69g
Gestational age at birth (days) 262 (26) 265 (23) 0.43h
Preterm birth (%)b 27 15 0.22i
Birth weight (grams) 2861 (932) 3105 (978) 0.20h
Birth weight (centile) 40 (25) 49 (32) 0.12h
IUGR (%)c 13 18 0.51g
Neonatal mortality (%)d 5 2 0.58i
Patient based recurrencef (n=41) (n=50)
Women with recurrent preeclampsia/HELLP (%) 27 28 0.90g
Women with recurrent hypertensive  
disease of pregnancy (%)
59 53 0.60g
Women with gestational hypertension 39 27 0.21g
No. of recurrences of preeclampsia/ 
HELLP per woman (range)
0-4 0-3 0.38j
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Table 2 | continued
a  Neonatal outcome of all births in study group (including index pregnancy).
b  Delivery before 34 weeks gestational age.
c  Intra uterine growth restriction (birth weight centile <p10).
d  Neonatal death (death during the first 28 days of life) and stillbirth (>15 weeks of gestation).
e  Neonatal outcome of all births after index pregnancy.
f  Percentage of multiparous women with one or more recurrences of preeclampsia/HELLP or  
 hypertensive disease of pregnancy (preeclampsia/HELLP or gestational hypertension).
g  Chi square test.
h  Independent samples t-test: mean (standard deviation).
i  Fisher’s exact test.
j  Mann-Whitney test: median (interquartile range).
DISCUSSION
In this retrospective study we analysed overall and future obstetric outcome in a series of 
women with decidual vasculopathy (DV) during their preeclamptic index pregnancy (DV 
positive), including recurrence rate of hypertensive disease of pregnancy (HDP). The control 
group consisted of women with preeclamptic pregnancy without evidence of DV lesions on 
histological examination (DV negative). The groups were comparable for the demographic 
characteristics, follow-up criteria and number of pregnancies (both total and pregnancies 
after the index preeclamptic pregnancy). In women with DV in their index preeclamptic 
pregnancy, there was a higher overall incidence of gestational hypertension, preterm birth, 
as well as lower neonatal birth and birth weight centiles in DV-positive group, without an 
increased incidence of HDP or preeclampsia. There was no increase in recurrence of PE or 
HDP, nor of other adverse pregnancy outcome parameters in future pregnancies. However, 
DV did relate to higher incidence of remote chronic hypertension.
Our hypothesis that preeclamptic pregnancies complicated by DV would be associated 
with increased recurrence of PE is not confirmed. Although our study presents the largest 
series reporting on future obstetrical outcome after documented DV on placental histology, 
a type-2 statistical error cannot be excluded, i.e. study sample being underpowered to 
detect difference in recurrence of PE. To address this issue, follow-up studies of larger 
cohorts of women after preeclamptic pregnancies could be a priority for collaborative 
network of centres with interest in PE research. Our outcome parameters were measured 
retrospectively via survey. Response rate of patients was 83%, which is in line with other 
questionnaire based European studies on PE [17-19]. The validity of a similar questionnaire 
was tested by Diehl et al., who found a sensitivity of 80% and specificity of 96% in verifying a 
history of PE, 20 years after index pregnancy [18]. 
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The association between DV and a wider range of adverse pregnancy outcomes, but not 
with recurrent PE, can be explained from the perspective of the heterogeneity of placenta-
related disorders. HDP, including PE and gestational hypertension from a maternal 
perspective, as well as placental abruption, fetal growth restriction and intrauterine death 
from the fetal perspective, are thought to be part of a continuous disease spectrum known 
as the placental syndrome. The fact that, in our study, the DV positive group showed an 
overall higher incidence of gestational hypertension and lower birth weight centile suggests 
that these patients could have an elevated obstetric risk with variable clinical phenotype. 
As gestational age and birth weight parameters did not differ significantly in the future 
outcome group, however, the association of DV with adverse outcome could by limited 
to the index pregnancy. This raises the question of whether this association is related to 
the pathophysiology of DV or merely considered as a confounding factor in severe PE. In 
line with current consensus of viewing PE as a heterogeneous disease, DV could be an 
expression of an underlying (vascular) pathology predisposing patients to both severe 
PE and chronic hypertension. The presence of the lesions in curetted endometrium of 
first trimester pregnancies [20-21] suggests they could be part of the cause of severe PE, 
rather than the effect of it. The association of DV with chronic hypertension prior to index 
pregnancy also suggests pre-existing pathology independent of the effect of severe PE on 
spiral artery pathology.   
The pathophysiological process underlying the adverse obstetric outcome in DV and 
the long term effect of the lesions on the spiral arteries is unknown. The association of 
DV with increased placental pathology and worse clinical outcome in women with PE is 
thought to be related to the fact that the lesions further aggravate spiral artery pathology 
and dysfunction [8]. Theoretically, the lesions could chronically damage the arteries, 
subsequently putting patients as risk for future obstetric complications. We argue that the 
development of a specific phenotype of placental syndrome is dependent on the severity 
and extent of DV changes in maternal spiral arteries whether or not mediated by interaction 
with specific fetal genetic repertoire expressed by the trophoblasts. 
Although it has been generally known that preeclampsia increased the risk for future 
cardiovascular disease, the association of DV with chronic hypertension after the index 
preeclamptic pregnancy in our series is striking. This, combined with our earlier finding 
that women with a history of PE with DV had mildly elevated cardiovascular risk factors 7 
months after index pregnancy [22], suggests these women to have an underlying pathology 
on a systemic level. Since our control group consisted of preeclamptic women with a 
comparable background, the adjusted odds ratio of 4.8 of developing chronic hypertension 
after a preeclamptic pregnancy with DV has important implications. First, it highlights 
the importance of placental examination in all cases of preeclampsia and the meticulous 
search for DV lesions both in the basal plate and membrane rolls. Second, the reporting 
of DV lesions on placental examination should alert the obstetrician to counsel these 
women regarding the higher risks of developing chronic hypertension and should advice 
an elaborate screening for cardiovascular risk factors. Third, from the perspective of the 
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heterogeneous aetiology of PE, we argue that preeclampsia with DV could constitute 
a unique group in which the development of PE is strongly related to chronic vascular 
(or endothelial) dysfunction rather than a primarily “placental” origin. If our results are 
confirmed by larger cohorts, the “DV positive” PE could characterise the group described 
by Roberts and Ness as “maternal” PE [23], and provide researchers with the opportunity to 
understand how sub-clinically dysfunctional blood vessels react to physiological changes 
during pregnancy leading to PE.
Several factors are thought to contribute to the development of DV. Both pre-existing 
vascular insult, caused by diabetes mellitus for example, as well as inflammatory factors 
and immune components, are thought to play a role. Supporting this is the fact that DV 
has also been observed in pregnant women with diabetes mellitus and auto-immune 
disease [24]. In line with the earlier mentioned theory of PE as a heterogeneous disease, 
these multiple etiological factors could converge into one outcome on a local level, namely 
defective placentation and DV [25]. Depending on additional maternal and fetal factors, 
these local pathological changes finally result in the manifestation of different components 
of the placental syndrome. 
A better understanding of the inflammatory, hemodynamic and metabolic pathways in-
volved in the etiology of DV could provide a subset of women with placental syndrome with 
a unique therapeutic opportunity. Aspirin is thought to augment uteroplacental blood flow 
mainly by inhibiting platelet function and reducing the risk of thrombosis, and, if started 
during the placentation stage (before 16 weeks of gestational age), has been shown to 
reduce ischemic pathological placental findings compared to non-treated women [26], and 
lower the incidence of PE and IUGR [27]. It is tempting to speculate that the protective effect 
of aspirin acts through prevention of the development of DV. Interestingly, women with pre-
eclampsia (with or without DV) in the present series did show a reduced overall incidence 
of HDP when treated with aspirin, suggesting that aspirin acts to prevent HDP on a mecha-
nism independent of or  downstream in the pathogenesis tree to the development of DV.
CONCLUSION 
Women with a history of DV associated PE have a higher overall incidence of pregnancy 
complications, as well as an increased risk of chronic hypertension, without altered 
recurrence of PE. In the near future, global research collaboration will aim at redefining the 
divergent aspects of PE and is expected to provide individualized therapeutic target for 
different subsets of the placental syndrome.
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ABSTRACT
Objective
Women with a history of preeclampsia (PE) have an increased prevalence of 
cardiometabolic, cardiovascular and prothrombotic risk factors. Remotely, these women 
are at increased risk of developing cardiovascular and thrombotic disease. Decidual 
vasculopathy (DV) describes vascular lesions in the maternal spiral arteries of the uterus 
which are found in approximately 40-60% of women with PE. DV is thought to be related 
to atherosclerosis because of their morphological similarity. The aim of this study is to 
investigate the association of cardiovascular and thrombogenic risk factors with DV in 
women with a history of PE. 
Study Design 
We retrospectively analyzed cardiovascular and thrombogenic risk of women with a history 
of PE, comparing cases with DV (n=95) to cases without the lesions (n=81) 7 months after 
index pregnancy. Data from a cohort of patients with a history of PE were matched with 
records from our pathology database.  
Results
The DV group showed higher diastolic blood pressure (73 vs. 70mmHg, p=0.031), lower left 
ventricular stroke volume (71 vs. 76 ml, p=0.032), higher total peripheral vascular resistance 
(1546 vs. 1385, p=0.009) and higher percentage of low plasma volume (34% vs. 19%, 
p=0.030). DV did not relate to other cardiovascular parameters, urinary protein, body mass 
index, lipid or glucose metabolism parameters or thrombophilia.
Conclusion
In this study, in women with a history of PE, cases with DV had increased cardiovascular 
risk, exhibiting circulatory alterations suggesting reduced venous reserves and elevated 
arterial tone, without metabolic or thrombophilic disturbances.
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INTRODUCTION
Preeclampsia (PE) is a major health problem worldwide [1]. It affects 5 to 8% of all 
pregnancies and is responsible for approximately 50,000 maternal deaths annually [1]. PE 
is defined as new onset hypertension and the development of proteinuria after 20 weeks 
gestational age [2]. The delivery of the placenta is the only known cure of this disorder [3].
Women with a history of PE have an increased risk of developing venous thrombosis and 
cardiovascular disease in later life [4-6]. Atherosclerosis and PE share many cardiovascular 
risk factors, such as endothelial dysfunction, hypertension, obesity, insulin resistance, 
hyperglycemia, hyperlipidemia and hypercoagulation (thrombophilia).  Many studies have 
observed significantly elevated hypertension parameters [7-10], low plasma volume [9], 
cardiac dysfunction [11], dyslipidemia [9-12] and elevated body mass index [10, 13] several 
years postpartum, in women with a history of PE, compared to normotensive controls. 
Glucose metabolism parameters of insulin [9, 14] and homeostasis model assessment 
of insulin resistance (HOMA-IR) [14] are also elevated in women with a history of PE. 
Additionally, thrombophilia could be associated with a higher relative risk to develop PE [15].
Decidual vasculopathy (DV) is a type of vascular lesions in the maternal spiral arteries 
of the uterus, observed in approximately 40-60% of women with PE [16-17]. The lesions 
are characterized by the presence of lipid-filled foam cells and vascular fibrinoid necrosis 
within the vascular wall and perivascular infiltration of inflammatory cells [18]. Although 
non-physiological remodeling is widely considered the hallmark of PE, the fact that DV is 
found in a proportion of patients with PE suggests a possible association with a specific 
subset of patients with the disease. This is in line with the current tendency to view PE as 
a heterogeneous disease or syndrome, such as maternal and placental PE, although these 
separate entities are not yet entirely defined. Because of the morphological similarity of the 
foam cell lesions of DV to atherosclerosis, these lesions are also named acute atherosis, 
although the latter term has also been used to describe the lipid filled macrophages 
specifically, with DV, or decidual arteriopathy, being more recent, general terms for spiral 
artery pathology [19]. It has been suggested that DV and atherosclerosis might have a 
similar etiological basis [20]. It is unclear whether DV in PE relates to a higher cardiovascular 
risk in later life. 
The aim of this study is to investigate cardio-metabolic, cardio-vascular and prothrombotic 
risk factors in formerly preeclamptic women with and without concomitant DV. We 
hypothesize that in women with a history of PE, cases with DV will have elevated 
cardiometabolic, cardiovascular and prothrombotic risk factors after index pregnancy, 
compared to cases without DV.
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MATERIALS AND METHODS
Cardiovascular risk data were obtained between 2004 and 2010 from a retrospective 
cohort of patients with a history of PE, which was previously approved by the Medical 
Ethics Committee of the Radboud university medical center on the 25th of October 2007. 
Data from the cohort were matched with records from the pathology database at the 
Radboud university medical center. PE was diagnosed according to established criteria [2]. 
Cases were included only if estimated cardiovascular risk measurements and histological 
placental analysis were performed following index pregnancy. 199 women were initially 
included. Diagnosis of PE of all patients was verified.  Women with incomplete records, 
incomplete placental samples and multiple pregnancy were excluded (n=23). 
Histological samples
Placental samples (n=176) had been examined macroscopically and microscopically 
by experienced pathologists and analyzed according to standard hospital protocol for 
PE. Placenta samples had been included of two or more membrane rolls, of the central 
and peripheral part of the placenta and of macroscopic abnormalities. The percentage 
of unmodified spiral arteries exhibiting DV changes was not assessed in the study as 
this requires a different setup with more extensive histological examination of placental 
basal plate. DV was defined as vascular fibrinoid necrosis and lipid filled foam cells in the 
vascular wall of spiral arteries in either the decidua basalis or parietalis (Figures 1 and 
2). Considering the initial analysis was not specifically targeted at DV and not all reports 
specifically described the presence or absence of the lesions, the research team reanalyzed 
all placenta specimens to re-evaluate the presence of DV. Mismatches (n=52) were re-
evaluated a second time with an experienced pathologist (J.B.). 
Cardiovascular and thrombogenic risk analysis
Cardiovascular and thrombogenic risk parameters analyzed were cardiovascular function 
(systolic blood pressure, diastolic blood pressure and mean blood pressure, heart rate, 
left ventricular stroke volume, left ventricular ejection fraction, mitral E/A ratio, left atrium 
diameter, total peripheral vascular resistance, uncorrected plasma volume and abnormal 
plasma volume corrected for lean body mass), proteinuria (total urinary protein per 
24 hours), body mass index, glucose metabolism (glucose, insulin or HOMA-IR), lipid 
metabolism (total cholesterol, LDL-cholesterol, triglyceride and HDL-cholesterol), and 
thrombophilia (low protein C,  low protein S, prothrombin mutation, antithrombin deficiency, 
heterozygous or homozygous factor V Leiden mutation or hyperhomocysteinemia). 
The following protocol was used by the study for the screening procedure for assessing 
cardiovascular risk. At the time of the exams the researchers were unaware of the 
vasculopathy status of the patients. Additional details are described elsewhere [9]. Arterial 
blood pressure was recorded in supine position at 3-minute intervals using a semiautomatic 
oscillometric device (Dinamap Vital Signs Monitor 1846, Critikon, Tampa, FL). 
209991-L-bw-stevens
61
Cardiovascular and thrombogenic risk of decidual vasculopathy in preeclampsia
5
 
 
Figure 1 
Figure 1 | Decidual vasculopathy in the decidua parietalis with fibrinoid necrosis (star), foam 
cells (arrow) and perivascular inflammatory infiltration (cross) (Haematoxylin and Eosin 50x).  
Source: department of pathology, Radboud university medical center.
Echocardiography to assess cardiac function was performed in semi-left lateral position 
after 5 minutes of rest, using a cross-sectional, phased-array echocardiographic Doppler 
system (General Electric Vivid 7, Horten, Norway). Mitral E/A ratio was obtained using 
pulsed-wave Doppler. Left ventricular ejection fraction was measured using the biplane 
Simpson’s rule. Stroke volume was calculated by multiplying the left ventricular outflow 
tract velocity time integral and the left ventricular outflow tract. The average left ventricular 
outflow tract time velocity integral of 5 consecutive ejections was used. Left ventricular 
outflow tract diameter was measured from the parasternal long axis view using two-
dimensional echocardiography at midsystole. Left atrium diameter was measured at 
end-systole. Total peripheral vascular resistance was calculated by 80 times mean arterial 
pressure divided by cardiac output (calculated as stroke volume x heart rate). 
Plasma volume was measured using the iodine125-human serum albumin (125I-HSA) 
indicator dilution method, as described elsewhere [21], and normalized for body surface 
area (in milliliters per square meter). Plasma volume less than 1,405 mL/m2 was 
considered abnormal. 
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 
Figure 2 
Figure 2 | Detail of decidual vasculopathy in the decidua parietalis with fibrinoid necrosis (star) 
and foam cells (arrow) (Haematoxylin and Eosin 400x).  
Source: department of pathology, Radboud university medical center.
Body mass index was calculated using the following formula: weight in kilogram / (length 
in meters)2. 24-hour urine sample was assayed to calculate total protein level (grams/24 h) 
(Aeroset). Insulin resistance estimation was based on the homeostasis model assessment 
of insulin resistance (HOMA-IR), using the following formula: [fasting serum insulin (mU/
l)×fasting plasma glucose (mmol/l)]/22.5. Glucose, insulin, total cholesterol, high density 
and low density lipoproteins, and triglycerides were measured with standard automated 
laboratory techniques (Aeroset). 
Factor V Leiden (F5 R506Q) and prothrombin (G20210A) mutation analyses were 
performed by routine polymerase chain reaction techniques. Plasma was assayed for 
protein C activity, free protein S and antithrombin activity. Plasma total homocysteine was 
measured by high-performance liquid chromatography (HPLC) assay. Thrombophilia was 
defined as Factor V Leiden mutation, prothrombin mutation, protein C activity <70%, free 
protein S <55% or antithrombin activity <85%. Hyperhomocysteinemia was defined as a 
fasting homocysteine more than 12.1 mmol/l.
Statistical analysis
The data was analyzed using SPSS 20.0 (Statistical Product and Service Solutions). 
Student’s t-test was used for parametric data and Mann-Whitney-U test was used for non-
parametric parameters. Grouped results were tested with the chi-square test or Fisher’s 
exact test where appropriate. P-values < 0.05 were considered significant. 
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RESULTS
The prevalence of DV was 40.4% before and 53.4% after revision (95 cases with DV and 81 
without DV).  The DV group was comparable to the control group for patient characteristics 
and follow-up time (Table 1). Median follow-up time between delivery and the time of 
cardiovascular risk analyses was 7 months for both groups, with a minimum of 2 and a 
maximum of 74 months (Table 1). In the index pregnancy, the DV group had a shorter 
gestational age and lower birth weight and birth weight centile (Table 1). Number of missing 
values were 0 for all parameters in Table 1, except for use of antihypertensives (n=2), 
gestational age (n=1), birth weight (n=1), and birth weight centile (n=5). 
In cardiovascular parameters, we observed a higher risk in the DV group for some of 
outcome parameters (Table 2). Diastolic blood pressure was statistically significant higher 
in the DV group. The group with DV also demonstrated lower left ventricular stroke volume, 
higher total peripheral vascular resistance, lower uncorrected plasma volume and a higher 
percentage of abnormal plasma volume corrected for body surface area. There was no 
difference between the groups for systolic blood pressure, mean arterial blood pressure, 
heart rate, cardiac ejection fraction, mitral E/A ratio and left atrium diameter. Number of 
missing values in cardiovascular parameters was 0 for blood pressure parameters and 
heart rate, 8 for stroke volume, 22 for cardiac ejection fraction, 18 for mitral E/A ratio, 23 
for left atrium diameter, 7 for total peripheral vascular resistance, and 6 for plasma volume 
parameters.
Table 1 | Background parameters of the group with decidual vasculopathy and the group without the 
lesions.
Parameter DV+ (n=95) DV- (n=81) p-value
Age at measurement (years) 31 ± 5 32 ± 5 0.071a
Age at delivery (years) 30 ± 5 31 ± 5 0.069a
Follow-up time (months) 7 (3) 7 (4) 0.884b
Use of tobacco (%) 15 7 0.127 c
Use of coffee (%) 56 53 0.720 c
Use of alcohol (%) 12 11 0.922c
Use of antihypertensive medication (%) 20 11 0.110c
Gestational age at birth (weeks) 30 ± 3 33 ± 4 <0.001a
Birth weight (grams) 1082 (530) 1541 (1276) <0.001b
Birth weight (centile) 9 (11) 23 (35) <0.001b
DV: decidual vasculopathy.
a  Student’s t-test, data are presented as mean with standard deviation.
b  Mann-Whitney-U test, data are presented as median with interquartile range.
c  Chi-square test, data are presented with percentage of cases
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Table 2 | Analysis of outcome parameters of group with decidual vasculopathy and the group 
without the lesions.
Parameters DV+ (n=95) DV- (n=81) p-value
Cardiovascular 
Systolic BP (mmHg) 122 (20) 118 (12) 0.085a
Diastolic BP (mmHg) 73 (11) 70 (10) 0.031a
Mean arterial pressure (mmHg) 90 (13) 86 (10) 0.059a
Heart rate (bpm) 72 (11) 70 (12) 0.116a
Stroke volume (ml) 71 (16) 76 (16) 0.032a
Ejection fraction (%) 64 (7) 64 (6) 0.895a
Mitral E/A ratio 1.6 (0.5) 1.6 (0.5) 0.646b
Left atrium diameter (mm) 37 37 0.400a
Total peripheral vascular resistance 1546 (406) 1385 (327) 0.009a
Plasma volume (uncorrected) 2631 (404) 2756 (420) 0.042a
Abnormal plasma volume  
(%, corrected for BSA)
34 19 0.038c
BMI (kg/m²) 23.7 (6.3) 24.4 (7.6) 0.996b
Urinary protein (g/24 h) 0.09 (0.07) 0.09 (0.06) 0.912c
Glucose metabolism
Insulin (mU/l) 11.0 (6.0) 11.0 (7.9) 0.852b
Glucose (mmol/l) 4.9 (0.5) 5.1 (0.7) 0.532a
HOMA-IR 2.4 (1.4) 2.4 (2.3) 0.889b
Lipid metabolism
Total cholesterol (mmol/l) 4.7 ± 0.9 4.7 ± 0.8 0.744a
HDL-cholesterol (mmol/l) 1.2 ± 0.3 1.3 ± 0.3 0.483a
LDL-cholesterol (mmol/l) 2.9 ± 0.9 2.8 ± 0.7 0.504a
Triglycerides (mmol/l) 1.0 (0.5) 1.0 (0.8) 0.922b
Thrombophilia (%) 11 14 0.580c
Factor V Leiden mutation (%) 5 4 1.000d
Protrombin mutation (%) 2 5 0.408d
Protein C deficiency (%) 1.3 2.1 1.000c
Protein S deficiency (%) 1.3 3.2 0.627c
Antithrombin III deficiency (%) 2.5 1.1 0.594c
Hyperhomocysteinemia (%) 15 17 0.700c
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Table 2 | continued
BP: blood pressure, BSA: body surface area, BMI: body mass index, DV: decidual vasculopathy, 
HOMA-IR: homeostasis model assessment of insulin resistance, HDL: high density lipoprotein, LDL: 
low density lipoprotein.
a Student’s t-test, data are presented as mean with standard deviation.
b Mann-Whitney-U test, data are presented as median with interquartile range.
c Chi-square test, data are presented as percentage of cases.
d Fisher’s Exact Test, data are presented as percentage of cases
Results for all other outcome parameters did not differ between the groups (Table 2). 
Body mass index and urinary protein were similar in both groups. Glucose homeostasis 
parameters (glucose, insulin and HOMA-IR) did not significantly differ between the 
two study groups. Lipid metabolism parameters (total cholesterol, LDL-cholesterol, 
HDL-cholesterol and triglycerides) did not differ significantly between the women with 
and without DV. Thrombophilia parameters (factor V Leiden mutation, prothrombin 
mutation, protein C deficiency, protein S deficiency, antithrombin III deficiency, 
hyperhomocysteinemia) were similar in both groups. Number of missing values was 0 for 
body mass index, 1 for urinary protein, 0 to 4 for glucose homeostasis parameters, 0 to 4 
for lipid metabolism parameters, and 2 to 9 for thrombophilia parameters. 
COMMENT
The aim of this study was to investigate whether the presence of DV is associated 
with increased cardiometabolic and cardiovascular and prothrombotic risk factors in 
women with a history of PE.  DV related to an increased risk for several of cardiovascular 
parameters. The lesions were associated with higher diastolic blood pressure, lower left 
ventricular stroke volume, higher total peripheral vascular resistance and lower plasma 
volume. DV was not associated with factors consistent with the metabolic syndrome or 
thrombophilia. In line with our previous study [22],  the DV group showed shorter gestational 
age and lower birth weight and birth weight centile than controls, in the index pregnancy. 
The results of our study suggest that women with a history of PE with DV have circulatory 
alterations suggesting reduced venous reserves and elevated arterial tone. The fact that 
DV patients demonstrate a normal body weight and glucose and lipid metabolism, without 
evidence of thrombophilia or renal dysfunction, indicates that DV in PE relates to an 
underlying hemodynamic condition rather than a metabolic or procoagulation state. The 
aberrances in cardiovascular parameters observed in the DV group could be interrelated. 
Plasma volume provides an indication of cardiovascular reserve capacity. Lowered venous 
reserves have been related to recurrent PE [21]. The diminished venous return results in a 
compensatory increase in sympathetic nervous system activity, leading to vasoconstriction 
and increased vascular shear stress and putting the vascular system at risk for hypoxia, 
endothelial dysfunction and platelet activation. Elevated sympathetic tone is evidenced in 
the study group by a higher peripheral resistance and diastolic blood pressure. The fact that 
heart rate was not elevated suggests vascular, rather than cardiac sympathetic nervous 
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system activation. Most likely, the observed elevated vascular resistance affects non-vital 
organs such as the uterus, a condition, which, in turn, has been related to subsequent fetal 
growth restriction [23]. Low venous capacity may also decrease cardiac preload, resulting 
in a lower stroke volume in the study group. It may be that this circulatory profile, affecting 
downstream micro-vasculature and circulation, also raises the risk on developing DV. 
Mimicking the way hypertension relates to the development of atherosclerosis, preexisting 
hemodynamic and vascular alterations could put the (already maladapted) spiral arteries 
of subclinical preeclamptic patients at risk for aggravation of vascular disease, and thus 
the development of DV. It needs to be noted though, that these findings are gathered 
post-preeclamptic pregnancy, and therefore the cause-effect relation of these results is 
uncertain and our findings will need to be further explored in future research. It is possible 
that the signs of cardiovascular dysfunction seen in this study, as well as DV itself, are not 
a manifestation of a preexisting pathology but rather result from a severe, early form of PE. 
As severe, early PE is an independent risk factor for cardiovascular disease [24] it is relevant 
to address the question of whether DV is part of the etiology of this (subtype of the) disease 
or a manifestation of it. The presence of the lesions in curetted endometrium of first 
trimester pregnancies [25, 26] suggests the former. Results from one large study suggest 
though that differences in BMI and blood pressure between women with a history of PE 
and normotensive controls were indeed present preconceptionally [27]. To confirm this, an 
ideal study set up would include primiparous women prior to conception. Our mean follow-
up time was seven months, which is generally accepted to be sufficient for the changes 
of pregnancy to normalize. To asses remote cardiovascular risk however, a much longer 
time between index pregnancy and measurement of cardiovascular parameters is needed. 
Additionally, parameters related to proposed etiology of DV need to be further explored. 
Research should focus on signs of endothelial dysfunction, and other proposed etiological 
process, such as immunological disease both on a systemic level as well as at the level of 
the uteroplacental unit. 
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ABSTRACT
Introduction
Decidual vasculopathy (DV) describes pathological changes of the spiral arteries observed 
in a subgroup of women with preeclampsia, which are associated with adverse clinical 
outcome. In preeclampsia, placentation is inadequate and aberrant trophoblast invasion 
and uterine natural killer (uNK) cell populations have been observed. How this relates to DV 
is unknown. 
Methods
Immunohistochemical staining was performed on placental samples of women with 
preeclampsia with DV, and compared to those of preeclamptic and normotensive controls, 
using markers for endothelial cells, trophoblast invasion, proliferation, and uNK cells.
Results
In all preeclamptic cases, the decidua parietalis appeared to contain a larger number of 
vessels compared to normotensive controls. In DV, the vessels took on a dilated aspect, 
and disruption of the endothelial layer was observed in severely affected arteries.  The 
trophoblast layer had a disorganized aspect in DV and trophoblast cells appeared to 
approximate the affected vessels. Additionally, uNK cells were observed in the perivascular 
inflammatory cell infiltrate surrounding DV.
Discussion
Hypertensive cases demonstrated an increase in the number of vessels in the decidua 
parietalis, possibly via neoangiogenesis, with endothelial disruption taking place in 
advanced DV.  The presence of uNK cells in the vicinity of affected vessels could point 
to a role of the maternal immune system in the pathophysiology of these lesions, with 
trophoblast cells being activated in reaction to this process.
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INTRODUCTION
Preeclampsia (PE) is a hypertensive disease of pregnancy that is almost entirely limited to 
humans [1]. The presence of placental tissue is a prerequisite for its development [2]. The 
primary location of the pathophysiology of the disease is thought to be the uteroplacental 
unit where maternal spiral arteries fail to complete the physiological process of adaptation 
to pregnancy [2]. Adaption of the spiral arteries is a crucial step to ensure adequate and 
constant blood flow to the developing fetus. It is thought to be the result of a carefully 
orchestrated interplay between invading fetal (trophoblast) cells and the maternal decidua 
and immune system. The failure of one or more of these steps leads to inadequate 
spiral artery remodelling, resulting in abnormal uteroplacental blood flow and placental 
dysfunction [2]. Despite extensive research on the subject the exact reason behind the 
defective placentation has not been found. 
The spiral arteries a proportion of preeclamptic women develop additional pathological 
changes. These changes are known as decidual vasculopathy (DV) or acute atherosis, the 
latter term having been coined for their similarity to atherosclerosis under light microscopic 
examination [3]. Morphologically, the lesions are characterised by fibrinoid necrosis and 
foam cell infiltration of the spiral artery wall, with additional features of perivascular 
inflammatory infiltration, mural hypertrophy and thrombosis [4, 5]. The lesions are seen in 
both the decidua parietalis underlying the fetal membranes as well as the decidua basalis 
of the uteroplacental plate [6]. DV relates to adverse clinical and neonatal outcome in PE [7]. 
The severity of the disease correlates with the number of vessels affected, as wells as their 
location in de decidua and additional morphological lesions such as thrombosis [6]. 
DV is often observed in association with spiral arteries which not invaded by trophoblasts 
and it has been suggested that its pathogenesis might be related to defective remodelling 
[8, 9]. It is unknown how DV relates to trophoblast invasion and differentiation. The fact that 
lesions similar to DV have also been reported in vessels of rejected transplantation tissue 
[10], and the presence of IgM and complement factor 3 in DV lesions [11] has led to the 
proposal of an alternative immunological etiology. Recent work on the role of the immune 
system in pregnancy has pointed out the importance of uterine natural killer (uNK) cells in 
the regulation of placentation and possible aberrant uNK population in PE [12]. Their role in 
DV remains unclear.
The purpose of this study was to analyse the way markers representative of the key cells in 
placentation relate to DV. We performed immunohistochemical staining on third trimester 
samples of basal plate decidua and decidua parietalis, comparing samples of pregnancies 
complicated by PE with DV to those of women with PE without the lesions, as well as to 
normotensive controls, analysing the following markers: 1) CD34 as a marker of endothelial 
cells, 2) CK7 as a marker for trophoblast invasion, 3) Ki67 as a marker for proliferation, and 
4) CD56 as a marker for uNK cells.
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MATERIALS AND METHODS
Population selection
In this study we performed immunohistochemical staining of placental sections from 
women with PE with DV as compared to samples of women with PE without the lesions 
as well as to samples of normotensive term and preterm pregnancies. This study was 
approved by the Medical Ethics Committee of the Radboud university medical center. 
Histological material of women with PE was selected from an existing patient group on 
which a reanalysis was performed by a pathologist experienced in placental analysis 
(J.B.) that had been specifically targeted at DV and its associated features [6-7]. The 
patient group was selected from women with PE who delivered between 1995-2010 at 
the tertiary hospital Radboud university medical center, based on the availability of clinical 
data and placental material. Cases with representative histological features were selected 
for this study, namely, five cases of women with PE and DV (of which DV was present 
in the decidua parietalis in four cases, and in the decidua basalis in four cases), as well 
as two cases of women with PE without histological evidence of DV. DV was defined as 
the presence of fibrinoid necrosis and foam cells in unremodeled spiral arteries, with or 
without perivascular lymphocytic infiltration or thrombosis. PE was defined as (new onset) 
hypertension (systolic blood pressure of ≥140 mmHg or diastolic blood pressure of ≥90 
mmHg) with proteinuria of ≥0.3 g/24 h urine or urine protein-to-creatinine ratio of ≥0.3 g/10 
mol, after 20 weeks gestational age [13].
Histological material from normotensive pregnancies was selected from the pathology 
database based on availability of placental material of all women who delivered between 
2000 and 2008. Two cases of uncomplicated normotensive pregnancies were selected. 
Three cases of preterm deliveries (<34 weeks gestational age) of unknown etiology without 
histological evidence of chorioamnionitis were selected as gestational age matched 
controls. 
All cases were required to have at least two membrane rolls, a sample from both central 
and peripheral placental parenchym as well as samples from any macroscopic anomalies. 
All placental material was previously analysed macroscopically according to hospital 
protocol. 
Tissue sampling and immunohistochemistry 
The placentas were preserved in buffered formalin 4%. From each placenta four full 
thickness sections were taken including the basal decidua. Two full thickness sections were 
also taken from the membrane rolls. The tissue samples were routinely processed and 
stained with haematoxylin and eosin. Four-micrometer-thick tissue sections were mounted 
on Superfrost glass slides (Menzel-Gläser, Braunschweig, Germany), deparaffinised and 
rehydrated through graded alcohols.
Of all placentas four-micrometer-thick paraffin sections were dewaxed, hydrated, and 
washed in buffered saline phosphate (PBS).  Endogenous peroxidases were blocked by 
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incubating the slides in phosphate buffered saline (PBS) containing 3% hydrogen peroxide 
for 30 min at room temperature and rinsed again in PBS. For antigen retrieval, sections were 
pretreated with Citrate (CD34 and Ki-67) or EDTA (Cytokeratin 7 and CD56). The placentas 
and membrane rolls were analyzed for the following markers, using the monoclonal 
antibodies depicted in Table 1: CD34 (a marker for vascular endothelium), Cytokeratin 
7 (a marker for trophoblast cells), Ki67 (a proliferation marker) and CD56 (marker for 
natural killer cells). All sections were incubated with primary antibodies for 60 min at room 
temperature. After rinsing in PBS, 30-min incubation with  Poly-HRP-antimouse/rabbit/rat 
IgG (Kit Powervision and  Poly-HRP-AntiMs/Rb/Rt IgG Biotin-free; Immunologic, Duiven, 
the Netherlands, code DPVO-999HRP, lot no. 30, 210–410) was performed for detection. 
Diaminobenzidine was used as chromogen. Sections were as usual briefly counterstained 
with Mayer’s haematoxylin. After dehydration in alcohol and histosafe, sections were 
mounted in Permout (Fisher Scientific, Fair Lawn, NJ). Appropriate positive and negative 
tissue controls were used throughout.
Table 1 | Antibodies, Dilution and Pretreatment procedures
Antibody 
specificity 
Clone Dilution Antigen 
retrieval 
Source
CD34 QBend /10 1:200 Citratea Immunologic, Duiven, The Netherlands
CK7 OVTL 12/30 1:800 EDTAb Immunologic, Duiven, The Netherlands
Ki67 MIB-1 1:100 Citratea Dako, Heverlee, Belgium
CD56 MRQ-42 1:500 EDTAb Cell Marque, Sanbio B.V., Uden, The Netherlands
a 10 mM Sodium citrate pH: 6.0, 95oC, 10 min
b 1 mM Tris-EDTA pH: 9.0, 95oC, 20 min
Histological analysis
J.B. and D.S. analysed the placental slides after immunohistochemical staining. All 
samples were analysed completely on a low field magnification and individual arteries were 
further studied on high field magnification. Findings were noted in a descriptive manner. 
Differences in findings between J.B. and D.S. were reanalysed discussed until an agreement 
was reached. Since the focus of the study was on DV, no comment was made on the 
staining patterns in villous tissue.  
RESULTS
Clinical data, DV characteristics and placental histology data are shown in Table 2. Mean 
gestational age was 31 weeks for the PE with DV group, 32 weeks for the PE only group, 
and 34 weeks for the preterm controls. Mean birth weight was 1298 grams (centile 13) in de 
PE with DV group, 1310 grams (centile 13) in de PE only group, and 2598 (centile 76) in the 
preterm control group.  Staining characteristics of individual markers are shown in Table 3. 
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Basic staining (Hematoxylin and Eosin, Figure 1 A-C)
In normotensive controls and cases with PE without DV, decidua parietalis contained 
spiral arteries with thin media without fibrinoid necrosis. In the decidua parietalis of case 
number seven spiral arteries with hypertrophic media were observed. Placental tissue of 
with decidua basalis of normotensive controls contained only a few spiral arteries with 
variable degrees of physiological remodelling. No remodelled spiral arteries are observed 
in the hypertensive groups. There were no signs of chorioamnionitis. Histological data of 
individual cases with DV and of additional placental parameters are described in Table 2.
Endothelial cell marker (CD34, Figure 1 D-F) 
The vessels in the membrane rolls of both term and preterm controls were small in calibre 
and few in number. In the decidua parietalis of both hypertensive groups the number of 
spiral artery per field appeared higher than in normotensive controls. Arteries with DV 
were larger in calibre and took on a dilated aspect. All groups demonstrated a similarly 
low number of vessels in decidua basalis. In normotensive cases and PE without DV, the 
endothelial layer appeared intact. In mild DV with fibrinoid necrosis without thrombosis, the 
endothelial layer had a disorganized, flayed, aspect, whereas in severely affected vessels 
with thrombosis it was partially or completely destroyed. 
Trophoblast cell marker (CK7, Figure 1 G-I)
Normotensive cases and PE without DV showed a thin, organized trophoblast layer 
overlying the decidua parietalis. In PE without the trophoblast layer appeared less organized 
than in normotensive controls. The layer of trophoblast cells in the fetal membranes in 
cases with severe DV was thicker and had a more disorganized aspect. CK7 positive 
cells appeared to encroach upon arteries with DV. Vessels with hypertrophic media also 
demonstrated perivascular infiltration of CK7 positive cells.
Table 3 | Staining characteristics
Antibody Cell type Staining 
localisation
Staining 
color 
Staining 
intensity
Staining variation Background 
staining
CD34 Vascular 
endothelial 
Membrane Brown Intense None None 
CK7 Trophoblast; 
epithelium of 
endometrium 
glands
Cytoplasmic Brown Intense All trophoblasts stain 
intensely except in the 
amnion layer
In areas 
with severe 
DV with 
thrombosis
Ki67 All 
proliferative 
Nuclear Brown Intense Variation in 
staining depending on 
stage of proliferation
None
CD56 Natural killer Membrane Brown Intense None None
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In the decidua basalis, all cases showed a large population of trophoblast cells without a 
clearly organized aspect. The spiral arteries in the decidua basalis demonstrated abundant 
invasion and infiltration of CK7 positive cells. In both hypertensive groups, decidua 
basalis demonstrated abundant diffuse staining of interstitial CK7 positive cells, without 
evidence of endovascular trophoblasts. Vessels affected by DV demonstrate fewer or 
no perivascular trophoblast cells which sometimes take on a fragmented aspect.  No 
endovascular trophoblast cells were observed. 
Proliferation marker (Ki67, not shown)
In preterm controls and both hypertensive groups a moderate number of Ki67 positive 
trophoblast cells where observed in the chorion layer of the membranes, with the decidual 
layer showing little positivity. In term samples, the number of cells showing proliferative 
activity was even lower in both layers. In the decidua basalis, all groups demonstrated a low 
percentage of Ki67 positive cells. In normotensive cases and PE without DV, proliferating 
cells were distributed evenly throughout the decidua parietalis and basalis, with no evident 
relation or proximity to spiral arteries. The perivascular inflammatory cells surrounding 
arteries with DV demonstrated Ki67 positivity in both decidua types. 
Uterine natural killer cell marker (CD56, Figure 1 J-L)
CD56 positive cells had the morphological appearance of lymphocytes. In both the 
membrane samples and the decidua basalis, both preterm and PE without DV cases 
showed a moderate to intense CD56 positive staining of uNK cells which was mostly limited 
to the deeper layer of the decidua. There was no evidence of clustering of uNK cells around 
spiral arteries, except in case number seven, which showed clustering of CD56 positive 
cells around hypertrophic spiral arteries. CD56 positive areas did not show trophoblast 
infiltration. Compared to the preterm controls very little CD56 positivity was observed in the 
term controls in both parts of the decidua.
DV cases demonstrated a relatively large population of CD56 positive uNK cells in the 
decidua parietalis.  The CD56 positive cells were present throughout the maternal decidua 
but in some cases were observed to encroach upon or enter the chorion layer. Additionally, 
the CD56 positive cells clustered around the vessels affected by DV. In the decidua basalis, 
cases with DV showed abundant CD56 positively clustered around the affected vessels. 
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DISCUSSION
In this explorative study we performed immunohistochemical staining on placental slides 
of women with PE with DV and those without the lesions, as well as control cases without 
hypertension. 
The decidua parietalis of preeclamptic women with DV appeared to show a larger number 
of vessels with the dilation of the affected arteries. The trophoblast layer of placental 
samples of women with the lesions was thicker and had a disorganized appearance 
compared to both hypertensive and normotensive controls. Additionally, trophoblast 
cells and uterine NK cells were observed to approximate the affected vessels, whereas in 
hypertensive and preterm controls the straining of CK7 and CD56 was limited to the fetal 
and maternal side, respectively. 
The impression of a higher number of spiral arteries in hypertensive cases is intriguing. 
Although this finding could also be due to increased tortuosity or branching of the spiral 
arteries, a true increase of the amount of vessels could suggest a role of neoangiogenesis 
in hypertensive disease of pregnancy. Hypoxia induced neoangiogenesis is a well 
described phenomenon, but a link between inflammation induced oxidative stress and 
vessel formation has also been proposed [14]. The latter mechanism is especially thought 
provoking as inflammation has been proposed as part of the pathogenesis of both PE and 
DV [15]. Additionally in DV, dilation of the vessels is observed, as well as partial or complete 
disruption of the endothelial layer. It is tempting to think that the pathophysiological process 
of DV weakens and eventually destroys the vessel wall leading to the aneurysmatic aspect 
of the vessels. It would be interesting to further explore the possible mechanisms behind 
this. Research could focus on makers for necrosis as well as those specific to endothelial 
dysfunction, such as von Willebrand factor or E-selectin [16]. 
The finding of relatively thicker and less coherent layer of CK7-positive trophoblasts in the 
fetal membrane deserves further consideration. The possibility of a stimulated proliferation 
in these cells is less likely due to the limited staining for the proliferation marker (Ki67), 
which did not show significant variation among the clinical categories. Alternatively, we 
propose that the development of DV in the decidua parietalis is associated with disruption 
of a control mechanism keeping trophoblasts in a compact and coherent layer within 
fetal membranes. In the vicinity of vessels with DV in the decidua basalis and even more 
prominently in the decidua parietalis, trophoblasts seemed to lose their tight intercellular 
attachment and breakthrough into the decidua to be in close contact with uNK cells and 
spiral arteries. Within the placenta bed fusion of extravillous trophoblasts into placental 
bed giant cells is suggested to limit their further invasion [17], and that this process is 
aberrant in PE [18]. Since true interstitial trophoblast invasion has not been described 
in fetal membranes and spiral arteries show certainly neither physiological remodelling 
nor endovascular trophoblast invasion, our findings may suggest an epiphenomenon by 
which trophoblasts react to decidual stimuli possibly from uNK cells affecting their stable 
existence within fetal membranes. 
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CD56+ uNK cells 
Foam cells 
CK7+ trophoblast cells 
CD34+ endothilium 
Normal vessel media  
Vessel  wall with fibrinoid necrosis 
Decidual stroma 
Chorion layer 
Amnion layer 
Figure 2 | Schematic representation of immunohistochemical staining patterns in fetal 
membranes with decidua from women with preeclampsia with decidual vasculopathy (right) 
compared to normotensive controls (left)
In this study, samples from cases in all groups demonstrated a low number of proliferating 
trophoblast cells, without evident differences between hypertensive cases with or without 
DV or normotensive controls. Interestingly, we observed that a part of the lymphocytic cells 
surrounding vessels affected by DV stained positive for Ki67, indicating these cells are 
proliferative. This could suggest an immunologically active role for these cells.  
CD56 positive uNK cells were present around vessels affected by DV. To our knowledge, 
this is the first study describing uNK cells in relation to DV. The maternal immune system 
is thought to play a vital role during early pregnancy [19]. In the first trimester u NK cells 
form the greater part of these immune cells consisting 70% of the total cell population 
[19]. As opposed to their systemic counter parts, the uterine NK cells are thought to be not 
primarily cytotoxic but instead are considered to play a vital role in spiral artery remodelling 
[19]. They regulate the migration of vascular smooth muscle cells by secretion of cytokines. 
Additionally, they could play a role in extravillous trophoblast migration. Their numbers 
are thought to decrease in pregnancy and their exact function in the third trimester is 
unknown [19]. Bachmayer et al. observed an increased number of uNK cells in decidual 
tissue from women with PE, combined with decreased IL-12 expression, which is thought 
to relate to disrupted placentation through decreased interferon gamma production [12]. 
Lockwood et al however, observed a decrease in uNK cell population in PE pregnancies 
[20]. As mentioned before, the presence of a perivascular lymphocytic infiltrate in DV is 
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well described. It is unknown whether these inflammatory cells are an early feature or if 
they are attracted later as part of a systemic reaction to cell damage, although the fact 
that perivascular cell infiltration is a common early feature in DV suggests the former [6-
7]. It is interesting to look at the role of NK cells in a broader perspective. Based on their 
morphological similarity to rejected transplant organs, an immune related etiology has 
been proposed for DV lesions [11]. 
In this study we observed evidence of aberrant trophoblast cell characteristics together 
with the presence of perivascular uNK cells in third trimester placental samples of women 
with DV in PE (Figure 2).  Additionally, in severe DV the endothelial layer was disrupted 
(Figure 2). It would be intriguing to explore the role of immune system in DV in greater 
detail. Further studies could focus on exploring the receptor and cytokine expression in DV, 
as well as the pathophysiology of the lesions in relation to trophoblast, uNK cells and PE 
itself.
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1. INTRODUCTION
The placenta is a unique organ developed solely and specifically to nurture and sustain 
the creation of a new life. Placental cells derived from the trophectoderm, which hence 
have fetal origin, interact directly with various maternal components of the decidua and 
myometrium to ensure the adequate establishment of the uteroplacental circulation. It is 
perhaps ironic that when the carefully orchestrated interplay between mother and fetus 
fails, it is this life-enabling organ itself that becomes a treat to not only the developing life 
but also the host itself. 
Abnormal placental development results in a spectrum of clinical disorders which probably 
share a common etiology.  They constitute the great obstetrical syndromes, which are 
the leading cause of maternal and neonatal morbidity worldwide [1]. Preeclampsia is 
the archetype of these placental dysfunction disorders as it strongly relates to the other 
components of the spectrum, such as fetal growth restriction (IUGR), placental abruption 
and fetal death. Historically, it has been observed that the placenta instigates the disorder 
and its delivery is followed by secession of symptoms. Decades of histological research 
have established characteristic lesions in placental specimens from women with 
preeclampsia, although disappointingly, none of these lesions were proven pathognomonic 
or ubiquitous in large scale collections. 
One lesion that is frequently encountered in severe cases of preeclampsia is decidual 
vasculopathy (DV), or acute atherosis, of maternal spiral arteries. This intriguing lesion 
has caught the attention of many pathologists since its first description by Hertig et al in 
1945[2]. Despite considerable advances over the past seventy years in the histological 
staining protocols and newer methods of tissue sampling and collection, DV remains the 
topic of debate among placental pathologists. In this review we will highlight the main 
controversies regarding the definition, terminology and prevalence of the lesion. We 
discuss the current hiatus in our understanding of its etiology and relation to the currently 
postulated mechanisms involved in the pathophysiology of preeclampsia. We will also 
discuss the impact of DV on clinical aspects of the disease and its relevance to other 
pathological lesions in the placenta. Finally, we will put forward a hypothesis linking three 
predisposing mechanisms to the development of the lesion in various clinical settings.
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2.  NORMAL SPIRAL ARTERY ADAPTATION AND ITS 
MALADAPTATION IN PREECLAMPSIA
Successful establishment of the uteroplacental circulation involves a complex multistep 
process necessitating adequate communication between the fetal trophoblast cells and 
the maternal host environment.  It is achieved by remodeling of small caliber muscular 
spiral arteries of the decidua and myometrium underlying the placenta, into large caliber 
vessels lacking smooth muscle cells, ensuring adequate and continuous blood flow toward 
the growing fetus [3]. In humans, the first step of spiral artery adaptation is trophoblast 
independent and involves endothelial vacuolization and swelling of individual muscle cells 
occurring at second half of each menstrual cycle. This is followed by further disorganization 
of smooth muscle layers under the influence of interstitially invading extravillous tropho-
blasts. During that time, trophoblast cells form endovascular plugs, providing a low oxygen 
milieu for the developing embryo during the first 8 weeks of gestation. Disappearance of 
these plugs from 8 weeks onwards provides the onset of placental function and coincides 
with retrograde invasion of endovascular trophoblasts along the lumen of the spiral arteries 
followed by their incorporation within the vessel wall.  The spiral artery wall is transformed 
and dilated, with the smooth muscle layer being replaced by fibrinoid material secreted by 
the embedded trophoblast cells. Human placentation is uniquely deep, in that the spiral 
artery conversation continuous until the upper third layer of the myometrium.
It is generally accepted that defective or incomplete spiral artery adaptation is central to the 
pathophysiology of preeclampsia (Reviewed in [1, 3]). Since the seminal finding by Brosens 
et al [4] of lack if physiological changes in the myometrial segments of spiral arteries in 
women with preeclampsia, this phenomenon has been confirmed by various authors [5-7]. 
Spiral arteries lacking physiological remodeling retain their intact muscular layer with the 
drawback of retaining recoiling capacity and responsiveness to vasoconstrictive stimuli. 
Consequently, the reduced lumen of myometrial segments of spiral arteries is suggested 
to cause placental hypoxia by reduction in intervillous blood flow. Recent insights into the 
rheological consequences of reduced spiral artery caliber suggest that it is the increased 
in spiral artery jet velocity within intervillous blood flow, rather than chronic hypoxia, that is 
responsible for the structural damage to the placental villous structure and the increased 
shedding of syncytiotrophoblast microparticles into the maternal circulation [8]. These 
microparticles, among other putative molecules including angiogenic factors, cause the 
abundant endothelial cell activation which is hallmark of preeclampsia and the substrate for 
the clinical signs and symptoms characteristic of the disorder [9].
Although lack of physiological changes of the spiral arteries was long held as the hallmark of 
preeclampsia, the fact that not all patients with the disease have defective remodeling brings 
nuance to this paradigm. Even in severe preeclampsia trophoblast invasion occurs in 44% of 
decidual and 18% of myometrial spiral arteries [6]. Moreover, defective remodeling is not lim-
ited to preeclampsia, but is associated with a number of clinical pregnancy disorders, such 
as IUGR, preterm labor and spontaneous abortion [1]. This again puts emphasis on the com-
plex, multifaceted pathogenesis of preeclampsia and other related diseases of pregnancy.
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3. DECIDUAL VASCULOPATHY: MORPHOLOGY, DEFINITION AND 
TERMINOLOGY 
In a proportion of cases with preeclampsia the spiral arteries show peculiar pathological 
changes at basal decidua and even more frequently in the decidua parietalis in delivered 
fetal membranes. A typical lesion encompasses fibrinoid necrosis and foamy cell 
incorporation of the vessel wall, with perivascular lymphocytic infiltration being variably 
included as an additional primary characteristic [10].
The most consistent feature of the lesion, sufficient to make the diagnosis, is the presence 
of fibrinoid necrosis of the vessel wall, however, acute atherosis has also been defined 
primarily as foam cell infiltration [6, 11]. Not much is known about the composition of 
the fibrinoid necrosis of DV. It is unclear if the lesion involves actual necrosis. It has been 
suggested it might be related to deposition of plasma components as a result of endothelial 
damage and increased permeability of the intima [12]. Fibrinoid necrosis is a typical lesion 
in systemic vasculitis, where is it thought to be related to an inflammatory process [13].
More is known about the foam cell lesions. The cells are histochemically identified as 
CD68+ macrophages. Katabuchi at al [14] analyzed the contents of the foam cells and 
found their cytoplasm was occupied by variously sized lipid droplets and membrane-bound 
myelin-like granules (myelinosomes) indicating cell membrane remnants. They concluded 
the foam cells in DV might be formed by the attraction of macrophages by the maternal 
system to remove damaged and necrotic cell material.
We and others have frequently observed perivascular infiltration of spiral arteries even 
without fibrinoid necrosis, and the nature of infiltrating cells and their contribution to the 
lesion is still speculative [15]. A less frequently encountered change occurring mainly in 
severely affected arteries is intraluminal thrombosis, hence considered as a secondary 
component [10]. Another morphological feature that has been observed in spiral arteries 
of women with complicated pregnancies, mainly by chronic hypertension, is medial 
hypertrophy without abundant fibrosis [10]. The link between DV with fibrinoid necrosis and 
medial hypertrophy is not fully understood.
There has been considerable debate among researchers on the morphological constituents 
of the lesion and also on the terminology used by them to describe it. Hertig et al [2], 
who first noted the lesion in necrotic segments in the placenta of preeclamptic women, 
described it as degenerative arteriolitis. It was Zeek et al [16] that coined the term acute 
atherosis, referring to the similarities to atherosclerotic lesions in the presence of foam 
cells and to the “acute” nature of development versus the more chronic and slow process 
involved in atherosclerosis. Despite the similarities on light microscopic examination 
between the decidual and early atherosclerotic lesions, the etiological and molecular basis 
of such a link is largely speculative [14, 17]. In our previous publications, we have proposed 
to use the term DV to designate this lesion. We argue that the word “decidua” deserves a 
place in the title as it is the tissue of origin of this lesion as opposed to the myometrium. 
Moreover, the presence of additional morphological features of the lesion justifies the use 
of a much broader term. 
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4. DECIDUAL VASCULOPATHY: CONTROVERSIES OF HISTOLOGICAL 
ANALYSIS
It is astonishing to note that in articles describing placental histological abnormalities 
mainly in the context of preeclampsia, DV has been reported in 4-85% of cases, although 
most studies describe prevalence between 40-50% [18-20]. The large variation of prevalence 
can be explained for the most part by vague definition criteria of the lesions and most 
importantly, the type and amount of tissue analyzed. For the analysis of DV the majority of 
studies utilized placental specimen available after vaginal or caesarean delivery. DV was 
most readily observed in the thin layer of the decidua parietalis adherent to delivered fetal 
membranes when this tissue was properly examined. The importance of including sufficient 
number of membrane rolls for histological examination cannot be overemphasized. In 
our practice, the inclusion of two fetal membrane rolls and the meticulous examination 
by an experienced pathologist would substantially increase the yield of finding DV in the 
specimen. Revision of 176 archived samples of placental tissue from 2004-2010 found 52 
mismatches in the diagnosis of DV, thereby increasing the prevalence of DV from 40% to 
53% [21]. 
DV has also been reported in (junctional) myometrial segments of spiral arteries, although 
it is relevant to note that routine placental specimens do not generally include myometrial 
tissue and therefore study of the deeper layers of the placental bed demands a different 
way of tissue sampling. This area of the uterus was an uninhabited terrain for researchers 
until the 1950s. In 1956 the first placental bed biopsies were taken which eventually led to 
the discovery of physiological remodeling in pregnancy and its failure in preeclampsia [4]. A 
disadvantage of this method is that a relatively small amount of the placenta bed is studied 
leading to biased prevalence of DV. A novel method of tissue sampling is decidual vacuum 
curettage of the placental bed after birth or caesarean section. This promising method was 
developed by Harsem et al. us yields adequate volumes of decidual tissue [22]. 
5. DECIDUAL VASCULOPATHY IS INDEPENDENT OF TROPHOBLAST 
INVASION AND SPIRAL ARTERY REMODELING
The frequent finding of DV in the decidual parietalis, where no invasion of interstitial 
nor endovascular trophoblast occurs, implies that the lesion develops independently of 
trophoblast-mediated spiral artery remodeling. Moreover, the lesions have been described 
in physiologically remodeled spiral arteries of the basal plate [6, 23]. However, the fact 
that DV is exclusively found in pregnancy (we are unaware of any reports of the lesions in 
non-decidualized endometrium), suggests that early “decidua-associated” remodeling of 
the spiral artery is a prerequisite for the development of DV. How the normal process of 
decidua-associated remodeling is accomplished in uncomplicated pregnancies and how it 
is disrupted in DV cases is still unknown. We speculate that it probably involves hormonal 
signals or merely the presence of non-invasive trophoblast in the vicinity of spiral arteries.
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This contradicts the common misunderstanding that DV develops only as a consequence 
of failure of trophoblast-mediated spiral artery remodeling in preeclampsia, although it 
is difficult to ignore that such unmodified spiral arteries are a frequently encountered in 
basal decidua. We propose that the failure to achieve complete physiological remodeling 
renders the vessels susceptible to secondary damage and subsequently the development 
of DV, yet this is not the only pathway that spiral arteries get damaged. Indeed, neither DV 
nor defective spiral artery remodeling are all-or-none phenomena, with a varying number of 
spiral arteries in both decidua and myometrium being partially or fully affected [3, 6, 24].
Conversely, like non physiological remodeling, DV is not limited to preeclampsia. The lesions 
have been described in other diseases of pregnancy and even, although rarely, observed in 
clinically normal pregnancies. DV has been described in IUGR [25, 26], gestational [27] and 
chronic hypertension [24], systemic lupus erythematosus [28], and diabetes mellitus [26]. 
This suggests that DV is not it is not the sine qua non for the development of the disease 
but probably shares some aspects of the pathophysiology of not only preeclampsia but the 
broader spectrum of placental dysfunction disorders. 
6. DECIDUAL VASCULOPATHY IS RELATED TO A WORSE CLINICAL 
OUTCOME IN PREECLAMPSIA
The earlier work of Brosens et al. (1972) elegantly showed in hysterectomy specimens 
with attached placenta the clear special association between DV and the presence of 
overlying areas of placental infarction [29]. Khong et al. found the presence of DV in women 
with preeclampsia to be associated with a shorter gestational age , which was confirmed 
by Moldenhauer et al. [30], but observed no difference in degree of proteinuria, severity 
and duration of hypertension or in other fetal outcome parameters [18]. Additionally, an 
association between presence of lesions and severity of the maternal disease [31], lower 
birth weight [20, 23] has been observed. Histologically, Fitzgerald et al. described an 
association of DV lesions with intraplacental hematomas [32]. 
We revisited the question of how DV relates to clinical outcome and analyzed the associa-
tion of individual morphological features of the lesions with maternal disease and neonatal 
morbidity [33]. The presence of DV was associated with a higher diastolic blood pressure, 
shorter gestational age, lower birth weight and lower umbilical artery pH. In histological 
parameters, DV related to a higher percentage of accelerated villous maturity. No differ-
ences were found in other placental parameters (placenta weight, infarctions, hematoma, 
calcifications), in maternal proteinuria or constituents of HELLP syndrome, or in additional 
neonatal outcome measures (birth weight centile, APGAR scores, and perinatal death). 
We then wondered whether DV lesions have a cumulative effect on clinical outcome [15]. 
DV was defined as the presence of fibrinoid necrosis in un-remodeled spiral arteries for 
the purpose of this study. The total number of vessels affected by DV correlated with 
disease severity (higher diastolic blood pressure and higher urine protein-to-creatinine 
ratio), adverse neonatal outcome (shorter gestational age, lower birth weight, 5 min APGAR 
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score and umbilical artery pH) and with placental pathology ( increased accelerated villous 
maturity, infarction and hematoma formation), but not with HELLP syndrome markers. The 
effect of DV on outcome was dependent on location and stage of the lesions. The number 
of affected vessels in the decidua basalis as well as vessels showing DV with thrombosis 
strikingly also correlated with increased perinatal mortality. Other morphological features, 
such as foam cell infiltration, did not add to correlation strength. 
7. DECIDUAL VASCULOPATHY AND ITS CURRENT ETIOLOGICAL 
CONCEPTS 
Cardiovascular
Hypothesized etiological mechanisms in DV have built on the resemblance of the foam 
cells to atherosclerosis, and related pathophysiological pathways have been proposed. 
Preeclampsia and atherosclerosis share many risk factors  and it is becoming increasingly 
clear that a history of particularly early preeclampsia is an independent risk factor for 
future cardiovascular disease [34]. Staff et al explored the relation of DV to atherosclerosis 
in their recent reviews [17, 35-37]. Central to their hypotheses is the current concept of 
viewing atherosclerosis as the result of a chronic inflammatory state. As preeclampsia 
also involves hyperinflammation they propose this to be the final common pathway for 
both DV and atherosclerosis. Their hypothesis includes that several factors might result 
in this final pathway, including immunological mismatch, altered shear stress due to 
non-physiologically remodeled arteries, or the dyslipidemia and oxidative stress seen in 
preeclampsia. Staff et al. also cover differences between DV and atherosclerosis such as 
the timespan in developing the lesions and the caliber of the vessels affected. A key step 
in the early formation of atherosclerosis is increased permeability of the endothelial layer 
caused by tissue injury which can by brought on by hypertension, dyslipidemia or oxidative 
stress. This is followed by the LDL entering the tissue, being oxidized and subsequently 
taking up by macrophages attracted from the blood stream, transforming them into foam 
cells [38]. Katabuchi et al studied the cell contents of foam cells in DV and found evidence 
of membrane cell material. They proposed that in DV they might not be part of the early 
pathology a but instead be the result of macrophages being attracted clean up necrosis and 
cells damage in an already advanced disease process [14]. 
Immunological
The presence of abundant fibrinoid material in DV was the first hint towards a possible 
immunological basis for DV. Fibrinoid necrosis is described in vessels from kidney 
transplant rejection and it is also a common feature of auto-immune vasculitis, leading 
researchers to speculate an immunological etiology for DV [26].
The exact nature of the fibrinoid material in vessels affected by DV in not fully revealed. In 
spiral arteries undergoing normal physiological changes, it is generally assumed fibrinoid 
is formed in vessel wall as a reaction to invading endovascular trophoblast [3]. This matrix-
type fibrinoid is an acellular homogeneous material and contains embedded intramural 
trophoblast, in contrast to the fibrin-type fibrinoid (fibrinoid necrosis) characteristic of 
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DV lesions. The latter thought to be derived from the deposition of fibrin generated by 
activation of the coagulation cascade [12]. Fibrinoid necrosis is not a feature of classic 
atherosclerosis [39].
The presence of lymphocytic cells around the lesions is another indicator of an 
inflammatory or immune reaction. Immunology plays a vital role in pregnancy. Trophoblasts 
only express HLA-C of all the major immune antigen complexes which react with maternal 
uterine natural killer cell (uNK) KIR-receptors. The combination of maternal uNK cell 
genotype KIR-AA and fetal extravillous trophoblast HLA-C2 genotype has the highest risk of 
preeclampsia, although it is unknown how this relates to DV [40]. 
Another important part of the decidual immune system are T regulatory cells (Tregs), 
which are thought to promote immune tolerance and have been found to be decreased in 
early preeclampsia [41]. Additionally, number of decidual Tregs correlates with the degree 
of HLA mismatch between mother and fetus in healthy term pregnancies, giving further 
credence to the notion that they facilitate maternal acceptance of an allogeneic fetus [42]. 
Interestingly, although the lesions are not separately described, in the study of Quin at el it 
was the severe early onset group, with deceased Tregs, which also had the highest placenta 
insufficiency index, which included DV. In the 80s studies have shown the presence of 
immunoglobulins and complement factors in the lesions of DV [26, 43]. 
8. HYPOTHESIS
The currently hold hypothesis attributes a central role to decidual inflammatory stress in 
the development of DV on which several pathways converge [37]. The evidence for decidual 
inflammation playing a central role in the pathogenesis of DV is inconclusive and draws 
largely from the accepted observation of systemic vascular inflammation in preeclampsia. 
The main critique to this hypothesis is that it fails to explain why DV occurs in only a subset 
of women with preeclampsia despite systemic inflammation being omnipresent, and why 
DV occurs in first trimester decidua before evident systemic inflammation ensues.
In line with current understanding of preeclampsia as a heterogeneous syndrome we 
propose to view DV as part of an alternate pathophysiological route which my lead to a 
separate subtype of preeclampsia or that, in synergy with additional factors, such as non-
physiological remodeling, leads to a more severe manifestation of the disease spectrum. 
As mentioned before, in preeclampsia neither defective placentation nor DV are all or one 
phenomena. Even in severe preeclampsia trophoblast invasion occurs in both decidua 
and myometrium [6]. Additionally, DV has been observed in physiologically adapted 
spiral arteries [6, 23]. This, in addition to the fact that both non-physiological adaptation 
and DV are not limited to preeclampsia, allows us to hypothesize that, although neither 
are all explaining etiological factors, both might separately or together contribute to the 
pathogenesis of the disease.  
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We start with the basic assumption that DV are lesions of the spiral arteries limited to 
pregnancy, as to our knowledge the lesions have not been described in non decidualized 
endometrium. This suggests the core of their genesis is related to or triggered by the 
conceptus itself. As the lesions of DV are readily observed in the decidua parietalis, it 
is reasonable to assume this trigger is not related to trophoblast invasion. It has been 
proposed that the lesions are a late phenomenon in preeclampsia and are a result of the 
systemic hyperinflammatory status that characterizes the disease [37]. Although not 
conclusive, a clue that the lesions might form earlier, is that they have been described in 
first trimester abortions [44, 45]. Limited amount of data from post mortem autopsies 
suggests the lesions not to be present in the systemic circulation [16], suggesting a local 
process to be involved, which raises the question why a systemic hyperinflammatory 
process would affect spiral arteries only. What then is this initial trigger and how do the 
separate morphological characteristics of the lesions develop?
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Figure 1 | Schematic representation of the proposed hypothesis on the etiology of decidual 
vasculopathy and the link to clinical disease. A trigger initiated by the conceptus (e.g 
immunological mismatch) results in perivascular lymphocytic cell infiltrate. Additional 
maternal (cardiovascular, metabolic or thrombogenic) or placental factors (abnormal spiral 
artery remodeling) damage the spiral arteries, making them susceptible to the development 
of full-blown decidual vasculopathy (DV) with fibrinoid necrosis, foam cells and ultimately, 
thrombosis. Maternal or placental factors only are proposed to result in “mild” spiral artery 
damage and therefore mild  hypertensive disease. The combination of both maternal and 
placental factors likely results in the most severe form of DV and spiral artery damage, leading 
to early preeclampsia with intrauterine  growth restriction or intrauterine fetal death.
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Based on our data on the prevalence of the different morphological characteristics of 
the lesions , we have proposed a chronology in their development [15]. As perivascular 
lymphocytic infiltration, with or without fibrinoid necrosis, was the most common lesion, 
we propose it to be the primary lesion in DV. This is in line with a proposed immunological 
or inflammatory origin of the lesions. Although the trophoblast cells overlying the decidua 
parietalis do not invade the spiral arteries, they are certainly in close contact with maternal 
immune regulatory cells which are abundant especially in the first trimester tissues. The 
perivascular infiltrate could be a manifestation of an immunological mismatch or an 
attempt of the maternal system to correct the issue (Fig. 1). The initial trigger of the lesions 
could even happen in an earlier phase, during the trophoblast-independent decasualization 
phase. It sets in motion a chain of events that will ultimately end in the development of 
all characteristics of DV. However, since not all vessels with perivascular infiltration show 
additional morphological lesions, we propose the continuation of this chain of events is 
dictated by additional factors. In other words, the initial trigger, which leads to perivascular 
infiltration, will not necessarily result in fully developed DV or, ultimately, clinical disease. 
We have previously shown that women with a history of preeclampsia and DV in the 
placenta had a higher incidence of cardiovascular risk factors 7 months after delivery [21] 
and an increased risk of long term chronic hypertension [46], suggesting an important 
maternal component to the lesions. We therefore propose that abnormal cardiovascular 
profile is one of the pathways leading to damage to spiral artery wall during early pregnancy 
triggering the development of DV. Alternatively, damaged spiral arteries from other 
mechanisms (Fig.1) are more susceptible to develop the later stages of DV (foam cell 
infiltration and thrombosis). 
It is possible that pre-existing vascular insult, as well as the presence of metabolic syn-
drome or thrombophilia act as catalysts to the pathological process and cause the reaction 
to spin out of control. Increased endothelial permeability and cell damage will subsequently 
lead to plasma leakage and fibrinoid necrosis. The maternal system will then attract 
macrophages which will ingest necrotic material and form foam cells. Thrombosis, the 
least frequent lesion is likely the last and most damaging lesion in this pathological process. 
The ultimate clinical outcome will then depend on the number of vessels affected, their 
location and their morphological characteristics, and whether the placental or the maternal 
contribution to the lesion is more dominant. It is possible that a “milder” degree of spiral 
artery damage will ultimately lead to only mild hypertensive disorder or even normal 
pregnancy, whereas complete lesions will lead to severe early preeclampsia, IUGR or even 
fetal death.
9. FUTURE PERSPECTIVES
It is tempting to revisit the etiology and clinical relevance of DV in light of the emerging 
concept of preeclampsia as a heterogeneous disease, with various risk factors, a complex 
pathophysiology and a spectrum of clinical presentation. In an effort to understand the 
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preeclampsia syndrome two predominant phenotypes have been proposed [47]: maternal 
and placental, although this dichotomous representation is probably oversimplified 
and each phenotype shares some aspects with the other. Maternal preeclampsia is 
characterized by exaggerated maternal response to a normally functioning placenta. 
The unfavorable maternal profile (cardiovascular, metabolic, or thrombogenic) results in 
systemic inflammation during pregnancy evident by markers of endothelial dysfunction. 
The placental phenotype is dominated by defective spiral artery remodeling, abnormalities 
in placental structure and function consequently affecting fetal growth. When combined, 
the maternal and placental components interact in an augmented way to cause the severe 
(maternal-placental) end of the clinical spectrum carrying the most threat to fetal and 
maternal wellbeing. 
Since the proposed etiology of DV implies the interaction of placental defects involving 
damage to spiral artery wall (with or without physiological remodeling) with unfavorable as-
pects of maternal profile (Fig.1), the lesion could serve as a paradigm of maternal-placental 
preeclampsia. If this model would be proven in the future it would have several implications. 
First, it would stimulate researchers to examine etiological aspects of DV in properly con-
ducted studies using uniform criteria to define the lesion. For this matter we compliment 
the collaborative efforts placental researchers and of fully endorse their recommendation 
for standardizing research protocols in preeclampsia [48, 49], which will undoubtedly ex-
pedite our knowledge of the pathophysiology of the syndrome. Second, it will identify the 
subgroup of pregnant women having the highest risk for developing preeclampsia and its 
related fetal and maternal morbidity. It follows that studies should be conducted to test 
performance of currently applied tools for predicting preeclampsia (maternal history and 
characteristics, biological markers and uterine artery doppler) in women who subsequently 
develop DV. This could open the window for individualized therapeutic interventions based 
on components of the maternal or placental syndrome predominant these women. Finally, 
although the relevance of DV lesion to the long term cardiovascular health is still unknown, 
this model singles out women with DV in postpartum counselling to be offered comprehen-
sive screening for cardiovascular, metabolic and thrombogenic risk factors and long term 
follow-up for the development of cardiovascular disease.
In conclusion, we review the available literature on DV, a lesion frequently observed in 
placental sections from pregnancies affected by severe preeclampsia. We address the 
pitfalls leading to a wide variation in definition and reporting of the lesion in studied 
conducted within the context of preeclampsia, and discuss controversial issues relating 
DV to maternal spiral arteries lacking the trophoblast-mediated physiological remodeling. 
Finally we scrutinize the current hypothesis on the etiology of DV in preeclampsia and 
propose a new hypothesis linking spiral artery wall damage to unfavorable maternal profile. 
This model could explain many confounding aspects of the preeclampsia syndrome in light 
of our current understanding of the syndrome.
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DISCUSSION 
In this thesis various aspects of decidual vasculopathy (DV) were explored, with emphasis 
on the relation of the lesion to preeclampsia and its consequences. This thesis provides 
insight into the way not only DV itself, but its individual morphological components relate 
to disease severity, neonatal outcome, and related placental pathology in preeclampsia. 
The long term obstetric outcome of women with a history of preeclampsia with DV and 
the association of the lesions with cardiovascular risk factors are discussed. Lastly, we 
focus on cell characteristics in histological samples of cases with DV and explore a novel 
hypothesis on the etiology of the lesions.  In this chapter we summarize our findings and 
discuss their implications for future research.
Clinical outcome
Preeclampsia and related disorders such as intrauterine growth restriction (IUGR) cause 
an important part of maternal and neonatal morbidity and mortality [1-3]. Thus far the 
only known cure of the disease is delivery of the placenta and conversely, the presence of 
the placenta is required for its development. Since Brosens et al first described disruption 
of placentation in preeclampsia [4], we have learned much about the complex interplay 
between mother and fetally-derived trophoblast cells that brings about the adaptation 
of the spiral arteries to insure adequate blood flow toward the placenta and ultimately 
determine the success of pregnancy. It was before this, in 1945, that DV were first 
described by Hertig et al [5] and many pathologists have made note of the lesions since 
then, however, many of the components of both their own pathophysiology and their 
relation to preeclampsia remain a mystery. From what we learned about spiral artery 
adaptation and its importance in insuring a successful pregnancy outcome, it was a natural 
theoretical step further to hypothesize whether the presence of these lesions would have 
a negative influence on uteroplacental flow, increasing placental disease and ultimately 
worsen clinical outcome. Earlier studies on this subject had produced inconclusive results 
[6-8]. 
The relation of DV to clinical and placental parameters in preeclampsia was explored 
(Chapter 2). A reanalysis of placental samples from preeclamptic pregnancies was 
performed to determine an accurate prevalence of DV. The lesions were than related to 
various clinical outcome and placental pathology parameters. The fact that the presence 
of DV in preeclamptic pregnancy was associated with a higher prevalence of accelerated 
villous maturity, a parameter associated with chronic underperfusion [9], and a higher 
diastolic blood pressure, as well as a shorter gestational age and lower birth weight, 
suggested the lesions to have an adverse effect on placental and clinical disease. We 
aimed to further explore this by analyzing the different morphological components of the 
lesions (Chapter 3). Previous studies had used varying types of tissue to study the lesions, 
as well as different morphological characteristics to define DV and it was unknown what 
their individual effect was on outcome parameters or if the influence of the lesions on 
clinical outcome was cumulative.  We observed a correlation between the total number 
of spiral arteries with fibrinoid necrosis (FN) and adverse clinical outcome, as well as 
increased placental pathology. Location and severity of the lesions themselves were the 
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most important factors effecting neonatal outcome as both the number of arteries with FN 
in the decidua basalis, underlying the placenta, as well as the number of arteries with FN 
and thrombosis correlated with perinatal death. 
Long term outcome
The fact that DV related to severe, early preeclampsia as well as adverse neonatal outcome 
raised the question of whether these lesions related to increased recurrence risk of 
hypertensive disorders. A history of preeclampsia is associated with a moderate increase 
in recurrence of the disease as well as an overall higher risk of pregnancy complications 
[10, 11]. More importantly, this risk is higher if preeclampsia occurred before 34 weeks 
gestational age [11]. We aimed to study whether women with a history of preeclampsia 
with DV had an increased long term incidence of pregnancy complications.
In order to explore this we developed a survey focusing on long term outcome in a cohort 
of women with a history of preeclampsia with and without DV (Chapter 4). The group 
which showed evidence of DV in the preeclamptic index pregnancy had an increased 
overall incidence of gestational hypertension and preterm birth, as well as an overall 
lower neonatal birth weight. Although a trend toward a worse future obstetric outcome 
was detected, the DV group did not have a significantly elevated recurrence risk of 
preeclampsia. Interestingly, the DV group had a higher prevalence of chronic hypertension 
both prior to index pregnancy and at time of survey, and the presence of DV was an 
independent risk factor for the development of chronic hypertension long term. This 
suggests women who develop DV could have an underlying pathology predisposing them 
to both severe preeclampsia and chronic hypertension. Although hypertension relates to 
this group of women, it does not form the defining mechanism in DV, as DV has also been 
described in normotensive IUGR and autoimmune disease [12, 13]. Like preeclampsia, DV 
does not seem to be defined by a single etiological factor or pathological mechanism. 
Cardiovascular factors
With the aim of further exploring possible underlying pathology in DV we studied the way 
DV related to cardiovascular and thrombogenic risk factors (Chapter 5). When the lesions 
were described by Zeek et al, they coined the term acute atherosis after the similarity of 
the lesions to atherosclerosis on light microscopic examination [14]. Preeclampsia and 
atherosclerosis share many risk factors and a history of early preeclampsia is associated 
with elevated risk of cardiovascular disease [15]. We compared women with a history of 
preeclampsia with DV to those with the disease but without histological evidence of the 
lesions. At 7 months post-partum, DV related to a mildly elevated diastolic blood pressure, 
lower left ventricular stroke volume, a higher total peripheral resistance and a higher 
percentage of low plasma volume, compared to cases without the lesions. However, DV 
were not associated with differences in body mass index, lipid or glucose metabolism 
parameters or thrombophilia. Our results provided further evidence that women with 
the lesions could have an underlying cardiovascular pathology, which is not related to 
metabolic syndrome or coagulative disturbances. 
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Histological factors
Although the pathological process underlying inadequate placentation and adaptation of 
the spiral arteries is not entirely clear, they related to aberrant trophoblast invasion and 
maternal uterine natural killer cell populations [16, 17]. As DV is often, but not exclusively 
observed in non-remodeled spiral arteries, the way the lesion relates to these possible 
etiological factors was worth exploring. We performed immunohistochemical staining 
using selected markers (Chapter 6). Cases with DV were compared to hypertensive and 
normotensive controls without the lesions. Hypertensive cases, with and without DV, 
appeared to have a higher number of vessels, which could be due to neoangiogenesis 
caused by hypoxia or oxidative stress. The endothelial layer of vessels affected by DV was 
disrupted in severe cases, suggesting that the pathological process of the lesion involves 
damage to the endovascular cell, but that this is not an early feature in DV.  The trophoblast 
layer of the fetal membranes was ticked and less organized in DV and the cells appeared to 
encroach upon affected vessels. As DV is most readily observed in the decidua parietalis, 
underlying the fetal membranes, where no trophoblast invasion occurs, their etiology is 
likely not related to an error in the invasion process and it is more likely that our findings are 
explained by a reaction to stimuli caused by DV or other components of the decidua such 
as uterine natural killer (uNK) cells. Interestingly, the perivascular inflammatory infiltrate 
around affected vessels stained positive for both proliferative and uNK cell markers, 
suggesting an active role of the maternal immune system. As not much is known about the 
role of uNK cells in the third trimester their role in DV is not yet clear. Although they do have 
cytotoxic potential, their function in the decidua is thought to be generally regulatory and 
immunosuppressive and their role in DV could therefore be of a reactive nature [18]. 
Hypothesis
In Chapter 7 we review the current literature on DV and formulate a novel hypothesis on 
its etiology. As mentioned before, an etiology related to atherosclerosis was proposed for 
the lesion. Staff et al further explored this theory [19-21]. Central to their hypothesis is the 
current consensus of chronic inflammatory state as a causative agent for atherosclerosis. 
In a parallel hypothesis, DV is proposed to be the result of the hyperinflammatory state 
observed in overt preeclampsia. We suggested this  theory to be incomplete as DV has 
been in observed in first trimester decidua [22], when no hyperinflammation is observed, 
combined with the fact that while hyperinflammation is both systemic and  present in all 
cases with preeclampsia, DV is observed only in a subset of women with the disease in the 
spiral arteries only. We discussed an alternate hypothesis. As DV seems to be limited to 
pregnancy, the formation of the lesions is likely triggered by the presence of the conceptus. 
In chapter 3 we analyzed the morphological characteristics of the lesions and observed 
that perivascular infiltration, with or without fibrinoid necrosis, is the most prevalent feature 
in DV, and we propose it to be the earliest characteristic of the lesion. An immune related 
etiology for DV was hypothesized, as the lesions are morphologically similar to those found 
in vessels of organ transplants which were rejected and immunoglobulins were observed to 
be present in DV lesions [23]. The perivascular infiltrate could be a sign of an immunological 
mismatch or an immunosuppressive reaction to it. We propose that the development of 
full blown DV will depend on additional factors. Results from our studies (Chapter 4 and 
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5) indicate women with a history of preeclampsia with DV to have elevated cardiovascular 
risk factors and increased prevalence of chronic hypertension. Pre-existing vascular insult, 
by chronic hypertension or spiral artery maladaptation, together with as of yet unexplored 
maternal (immune) factors, are proposed to act as catalysts to the pathophysiological 
process of the lesions, ultimately resulting in full blown DV. Clinical outcome will depend on 
number of arteries affected and severity of DV lesions, as well as which additional placental 
and maternal factors are involved. 
Conclusions and indications for future research
Continuing along the line of viewing preeclampsia as a heterogeneous disease, DV could 
represent a group with combined components of the placental (spiral artery pathology) 
and maternal subtype (chronic hypertension, uNK cells). This could signify these women 
to be a group with an even higher risk during pregnancy, as well as long term, putting 
them in need of guided counseling and possibly individualized (prophylactic) treatment by 
their physicians. Firstly, the etiology of DV needs to be further explored in larger studies 
conducted using uniform protocols to define the lesion. Focus could be on the role of the 
maternal immune system, especially the immunohistochemical analysis of uterine NK 
cells and related cytokines, but also other components, such as regulatory T cells and 
their function in preeclampsia with DV. Secondly, studies could be developed to analyze 
predictive factors for women with preeclampsia with DV and develop a predictive model. 
Currently these women, who are at elevated risk for adverse outcome in their index 
pregnancy, can only be diagnosed with DV on histological examination post-partum. As 
predictive models were more effective when several factors where used [24], studies could 
focus on combining maternal characteristics (comorbidity), with blood markers (angiogenic 
factors) as well as ultrasonic markers (uterine artery flow). Studying DV could provide 
us with insight into not only the pathophysiological mechanism underlying the lesions 
themselves, but also into a subgroup of women with preeclampsia and related placental 
disorders who have elevated risk of adverse outcome not only during pregnancy but also 
long term. 
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Summary
The subject of decidual vasculopathy (DV) is introduced in Chapter 1. Preeclampsia is a 
hypertensive disorder of pregnancy of responsible for a significant part of maternal and 
neonatal morbidity and mortality worldwide. The etiology of preeclampsia is unknown and 
it’s been suggested multiple pathophysiological pathways are involved, leading to variable 
clinical manifestations. However, an important part of its pathophysiology is thought to 
originate in the failure of the adaptation of maternal spiral arteries to pregnancy. DV, or 
acute atherosis, are additional pathological changes that develop in the spiral arteries of a 
subgroup of preeclamptic women, which theoretically further disrupt vascular function and 
ultimately worsen clinical outcome.
How DV relates to maternal and neonatal outcome, as well as placental pathology in 
preeclampsia, is explored in Chapters 2 and 3. Earlier studies on this subject had produced 
inconclusive results. We performed a reanalysis of individual morphological features of DV, 
using placental samples from preeclamptic pregnancies. We then related the presence of 
DV and its morphological features to clinical outcome and placental parameters. DV, as well 
as the number of vessels with the lesions, related to adverse clinical outcome and increased 
placental pathology. Moreover, the number of spiral arteries with DV in the decidua basalis 
underlying the placenta, and the number of affected vessels with thrombosis also related to 
increased perinatal death. 
A history of particularly early, severe preeclampsia is associated with increased risk of 
recurrence of hypertensive disease of pregnancy and adverse obstetric outcome. The 
association of DV in preeclampsia with long term outcome is described in Chapter 4. 
Women with a history of preeclampsia with DV in the index pregnancy had an increased 
overall, but not future, incidence of gestational hypertension, preterm birth and a lower 
overall neonatal birth weight. Additionally, the presence of DV in the index pregnancy was a 
risk factor for developing chronic hypertension long term. It is possible that these women 
have an underlying pathology predisposing them to both severe preeclampsia and chronic 
hypertension.
In Chapter 5 we studied the way DV related to cardiovascular and thrombogenic risk 
factors. A history of particularly early preeclampsia puts women at elevated risk for future 
cardiovascular disease. In addition to the association with chronic hypertension, a possible 
connection of DV to cardiovascular disease was previously theorized as the lesions are 
similar to atherosclerosis on microscopic examination. We observed that DV in the index 
pregnancy related to mildly elevated cardiovascular risk factors, but not to disturbed lipid or 
glucose metabolism parameters or thrombophilia, 7 months after delivery.
We explored the way DV related to decidual cells populations and vessel characteristics 
in Chapter 6. DV is often observed in spiral arteries that lack adequate remodeling of 
pregnancy and aberrant trophoblast and maternal uterine natural killer cell populations 
were observed in these non-remodeled vessels.  The trophoblast layer of the fetal 
membranes lacked coherency in DV cases  and the cells appeared to encroach upon 
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affected vessels, possibly due to a reaction to stimuli caused by DV or other components 
of the decidua. One of the morphological characteristics of DV is perivascular inflammatory 
cell infiltration and we found these cells stained positive for uterine natural killer cell 
markers, suggesting an active role of the maternal immune system. 
In Chapter 7 we proposed a new hypothesis on the etiology of DV and current literature on 
the lesions was reviewed. The previously proposed hypothesis of DV being the result of the 
hyperinflammatory state observed in overt preeclampsia, parallel to the current consensus 
on the etiology of atherosclerosis, is reviewed. As hyperinflammation is present in all cases 
with preeclampsia but manifests at a later stage of the disease, whereas DV is present 
in a subgroup of women with the disease and has been observed in the first trimester of 
pregnancy, we chose to formulate an alternative hypothesis. As DV seems to be limited to 
pregnancy, we propose the conceptus to be a trigger in the development of DV. Perivascular 
inflammatory cells are the most prevalent feature in DV, suggesting they are an early feature 
of the lesions. The perivascular infiltrate could be a sign of an immunological mismatch or 
an immunosuppressive reaction to it. The development of full blown DV will then depend 
on the whether additional factors, such as pre-existing vascular damage or other maternal 
(immune) factors are present. Clinical outcome will depend on number of arteries affected 
and severity of DV lesions, as well as which additional placental and maternal factors are 
involved.  
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SAMENVATTING
Het onderwerp deciduale vasculopathie (DV) wordt geïntroduceerd in Hoofdstuk 1. 
Pre-eclampsie is een hypertensieve aandoening van de zwangerschap welke verant-
woordelijk is voor een belangrijk deel van de moeder en kind ziekte en sterfte in de wereld. 
De oorzaak van pre-eclampsie is niet bekend en er is gesuggereerd dat de ziekte mogelijk 
meerdere oorzaken heeft die leiden tot de verschillende klinische uitingsvormen van 
de ziekte. Een belangrijke factor in de pathofysiologie van de ziekte lijkt zijn oorsprong 
te vinden in de inadequate aanpassing van de maternale spiraal arteriën tijdens de 
zwangerschap.  DV, of “acute atherosis”, zijn additionele pathologische veranderingen van 
de spiraal arteriën, welke voorkomen in een subgroep van vrouwen met pre-eclampsie. 
In theorie kunnen de laesies lijden tot een verdere verslechtering van de vaatfunctie en 
uiteindelijk van klinische uitkomsten.
De manier waarop DV relateert aan maternale en neonatale ziekte-uitkomsten, alsmede 
aan placenta pathologie, in pre-eclampsie, wordt beschreven in Hoofdstukken 2 en 
3. Resultaten van eerdere onderzoeken naar dit onderwerp waren niet conclusief. We 
hebben een heranalyse verricht van de individuele morfologische karakteristieken van DV, 
gebruikmakend van placenta coupes van vrouwen met pre-eclampsie. Hierna hebben we 
de aanwezigheid van DV en de morfologische kenmerken van de laesies vergeleken met 
klinische uitkomsten en placentaire parameters. De aanwezigheid van DV, en het aantal 
vaten met DV, correleerde met slechtere klinische uitkomsten, alsmede toegenomen 
placenta pathologie. Hiernaast was er een relatie van het aantal vaten met DV in de decidua 
basalis onderliggend aan de placenta, alsmede van het aantal vaten met DV en trombose, 
met verhoogde incidentie van perinatale sterfte.
Een voorgeschiedenis van met name vroege, ernstige pre-eclampsie is geassocieerd 
met een verhoogd herhalingsrisico op hypertensieve aandoeningen in de zwangerschap 
en met negatieve zwangerschapsuitkomsten. De associatie  van DV met lange termijn 
uitkomsten bij pre-eclampsie wordt beschreven in Hoofdstuk 4. Vrouwen met een 
voorgeschiedenis van pre-eclampsie met DV in de index zwangerschap hadden verhoogde 
algehele, maar niet toekomstige, incidentie van zwangerschapshypertensie, vroeggeboorte 
en een lager neonataal geboortegewicht. Tevens was de aanwezigheid van DV in de index 
zwangerschap een risicofactor voor het ontwikkelen van chronische hypertensie op de 
lange termijn. Het is mogelijk dat deze vrouwen een onderliggende aandoening hebben 
welk het risico op het ontwikkelen van pre-eclampsie en chronische hypertensie verhoogd. 
In Hoofdstuk 5 onderzochten we de manier waarop DV relateert aan cardiovasculaire en 
trombogene risicofactoren. Een voorgeschiedenis van met name vroege pre-eclampsie 
verhoogd het lange termijn risico op hart- en vaatziekten. Naast de eerder beschreven 
associatie met chronische hypertensie, werd een mogelijk verband tussen DV en hart- en 
vaatziekte eerder al gesuggereerd, vanwege het feit dat de laesies bij microscopische 
analyse lijken op atherosclerose. We stelden vast dat DV in de index zwangerschap was 
geassocieerd met een milde verhoging van cardiovasculaire risicofactoren, maar niet aan 
een afwijkend glucose en lipide  metabolisme of aan trombofilie, 7 maanden post partum. 
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We onderzochten de relatie tussen DV en cel populaties in de decidua alsmede 
vaatkarakteristieken in Hoofdstuk 6. DV wordt vaak gezien in de spiraal arteriën die niet 
goed worden aangepast tijdens de zwangerschap. Tevens zijn afwijkende trofoblast en 
uteriene naturalkillercel (uNK) populaties beschreven in deze niet aangepaste vaten. De 
trofoblastlaag van de foetale membranen toonde een verlies van samenhang bij casus 
met DV en de cellen leken aangedane vaten te benaderen, mogelijk als reactie op stimuli 
veroorzaakt door de laesies zelf of door andere onderdelen van de decidua. Een van de 
morfologische kenmerken van DV is perivasculaire infiltratie van ontstekingscellen en we 
zagen dat deze cellen aankleurden met markers voor uNK cellen, wat suggereert dat het 
maternale immuun systeem een actieve rol speelt in DV. 
In Hoofdstuk 7 formuleren we een nieuwe hypothese over de etiologie van DV en 
bespreken we de huidige literatuur over de laesies. De voorgaande theorie aangaande de 
etiologie van DV stelt voor dat de laesies ontstaan als gevolg van de hyperinflammatie 
welke gezien wordt in klinische pre-eclampsie, een hypothese die een parallel vormt aan 
de huidige consensus waarin het ontstaan van atherosclerose wordt gerelateerd aan 
chronische inflammatie. Aangezien hyperinflammatie in pre-eclampsie in een later stadium 
en bij alle vrouwen met ziekte gezien wordt, waarbij DV daarentegen slechts bij een deel 
van de patiënten en mogelijk al in het eerste trimester beschreven wordt, kozen wij ervoor 
een nieuwe hypothese te formuleren. DV lijkt alleen in de zwangerschap voor te komen, 
en we stellen voor dat de zwangerschap zelf de uitlokkende factor vormt voor DV. De 
aanwezigheid van perivasculaire ontstekingscellen is de meest prevalente afwijking bij DV, 
wat suggereert dat dit een vroeg kenmerk van de laesies is. De ontstekingscellen zouden 
een teken van immunologische mismatch kunnen zijn of een immuun-onderdrukkende 
reactie hierop. De verdere ontwikkeling van de laesies van DV is afhankelijk van het al dan 
niet aanwezig zijn van aanvullende factoren, zoals pre-existente vaatschade of andere 
maternale (immuun)factoren. Klinische ziekte-uitkomsten zijn afhankelijk van het aantal 
aangedane vaten en de ernst van de laesies, alsmede de aanwezigheid van additionele 
placentaire en maternale factoren. 
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Dit proefschrift zou er niet geweest zijn zonder de hulp, steun, het geduld en de liefde van 
heel veel mensen.  Graag zou ik iedereen bij naam willen bedanken. Maar, zo heb ik me 
laten vertellen, dit is het deel van het proefschrift dat door iedereen gelezen wordt. Het 
zou zonde zijn om iedereen door een tien pagina lange lijst met namen te laten worstelen. 
Hierbij dus de verkorte versie.
Geachte Prof. van Vugt, beste John, als mijn promotor was je altijd beschikbaar voor advies 
en commentaar. Je nam de rol van mijn directe begeleider over toen Marc en Salwan naar 
Maastricht gingen en je hebt deze altijd met veel rust en geduld vervuld. Heel erg bedankt 
voor alles.
Geachte Prof. Spaanderman, beste Marc, ik vind het heel erg fijn dat ook jij mijn promotor 
bent. Je hebt me enorm geholpen met je scherpe blik en je vermogen om me vraagstukken 
te laten bekijken vanuit een ander perspectief. Je enthousiasme en oprechtheid hebben me 
meer dan eens door moeilijke periodes gesleept. Dank voor je inspiratie.
Geachte Dr. Al-Nasiry, beste Salwan, als mijn copromotor bent jij meer dan ieder ander 
verantwoordelijk voor het mogelijk maken van de lange reis die uiteindelijk tot dit 
proefschrift heeft geleid. Wie had dit kunnen denken toen ik als medisch student, vers terug 
uit Tanzania, bij jou aanklopte voor mijn wetenschappelijke stage, over iets dat “deciduale 
vasculopathie” heette… Zoals alle reizen die er toe doen, was het niet altijd makkelijk en 
was er menig obstakel te overwinnen en berg te beklimmen. De afstand tussen Maastricht 
en Nijmegen kon soms erg groot zijn. Echter, zonder jouw steun, je bijdrage, je al dan niet 
kritische noot, je vechtlust, je ambitie en je warmte zou ik niet zijn waar ik nu ben. Dank voor 
alles. Ook bedankt voor de gastvrijheid van je gezin. 
Geachte Dr. Bulten, beste Hans, mijn copromotor en begeleider in alles wat met pathologie 
te maken heeft en meer dan dat. Menig uur hebben wij samen door microscopen getuurd 
en gesproken over onze bevindingen. En tijdens die vele dagen was je altijd bereid je 
voorraad fruit en andere lekkernijen te delen. Ook kon ik altijd bij je terecht als ik een 
luisterend oor nodig had. Heel erg bedankt voor al je steun (ik hoop dat je het niet erg vind 
dat ik toch gynaecoloog wil worden). 
Veel dank ook aan de waardevolle bijdrage van alle co-auteurs. Beste Marcela, bedankt voor 
het harde werk dat je geleverd hebt voor de DEVAP 1 studie (Hoofdstuk 5). Veel succes met 
je verdere carrière. Beste Margot, dank je voor al je hulp bij de DEVAP 2 studie (Hoofdstuk 
4) , super dat er zo’n mooie publicatie uitgekomen is. 
Verder ben ik ook veel dank verschuldigd aan alle vrouwen die mee wilden werken aan de 
DEVAP studies. Zonder jullie zou dit proefschrift er niet zijn. 
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In maart 2011 begon mijn carriere als arts bij de gynaecologie in het Radboud universitair 
medisch centrum en ik heb hier enorm veel geleerd. Geachte Prof Vandenbussche, 
beste Frank, dank voor het vertrouwen dat je reeds vanaf het begin in mij had. Geachte 
dr. Bekkers, beste Ruud, heel erg bedankt voor de steun die je me de afgelopen jaren 
gegeven hebt. Geachte Prof. Lotgering, dank voor alle wijze lessen, het is een eer dat u deel 
uitmaakt van mijn promotiecommissie. Joris, dank dat ik altijd bij je terecht kon voor al mijn 
promotie lief en leed. Maaike, Petra, bedankt voor alle wijze onco- en levenslessen. Dank 
aan iedereen die ik nu niet bij naam kan noemen. Dank ook aan alle arts-assistenten en 
onderzoekers. In het bijzonder de ANIOS voor intimi: Amy, Christine en Suzan. Wine really 
does fix everything. 
Aan alle medewerkers van  de gynaecologie van het Zaans medisch centrum, alle 
gynaecologen, arts-assistenten, verpleegkundigen, secretaresses, doktersassistentes, lieve 
iedereen. Wat is dit een fijne plek om te werken, wat ga ik jullie allemaal ontzettend missen. 
Wat zou ik jullie graag allemaal bij naam willen bedanken. Geachte dr. Bayram, beste 
Neriman, je bent een fantastisch opleider, je windt er geen doekjes om en hebt een hart van 
goud. Heel erg bedankt voor alles. Sanne, mijn partner in promotie crime, wat stoer dat we 
straks allebei “echt dokter” zijn. Wanneer gaan we pre-eclampsie week houden? 
Alle leden van de fellowship, Pia, Niek, Roel, Miski. Ooit gaan we samen een prive kliniek 
beginnen op een subtropische lokatie. Lizel, ga je dan ook mee? Charlene, Adilson, Chantal, 
Patricia, Fran, Jesus, jullie zijn de allerliefste schoonvrienden die ik heb.
Sweet Chisty, a lot has changed since the crazy summer of 2009. It’s been some ride. 
You are, and will always be, my family. Thanks monks, love ya. Dear Ramona, can you 
believe that we met almost fourteen years ago? And yet it seems like yesterday we were 
picking veggies under the burning Australian sun. You’re an example of the fact that a 
true friendship doesn’t require proximity. Querida Paty, tu y tu madre me han hecho sentir 
realmente bienvenida en Quito, mi segunda casa. Me alegra mucho que pudieran visitar mi 
casa tambien (aunque insistieran en ir a ver el barrio rojo).
Lieve opa en oma van Vliet, jullie waren er altijd, een echte opa en oma. Dank voor alle 
liefde, logeerpartijtjes en pannekoekbaklessen tijdens het camperen.  Lieve opa en 
oma Stevens, wat ben ik trots op mijn afkomst, een echte mijnwerker en een slimme 
carrierevrouw die huismoeder werd. We schijnen zelfs een bokkenrijder als voorouder te 
hebben! Ik mis jullie en ik hoop dat jullie ook trots op mij zijn. Lieve Minoe, lief meisje, ook jij 
hoort hierbij, ik hoop dat je nog af en toe naar me kijkt daarboven. 
Beste Hans, als het gaat om nature versus nurture was jouw bijdrage aan de eerste groter 
dan aan de tweede. Mijn aanleg voor beta vakken heb ik zeker aan je te danken. Zou een 
voorliefde voor whisky ook genetisch zijn?
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A mis suegros, Maria y Manuel, y el resto de la familia en España. Muchas gracias por 
vuestro apoyo a esta “medica de sangre”.  Gracias por acogerme en vuestra familia y 
hacerme sentir parte de ella.
Lieve Steven, 12 jaar ouder en twee keer zo groot, je bent de ultieme grote broer. Dank dat 
je er altijd bent voor je kleine zus. Lieve Els, dank je voor je onmisbare bijdrage aan jullie 
fantastische gezin. Lieve Floran, Felien en Manèl, jullie zijn de beste neefjes en het beste 
nichtje van de wereld. Gaan jullie echt allemaal langer worden dan ik? 
Lieve mam, ik denk niet dat ik ooit de juiste woorden zal vinden om je te bedanken voor 
alles wat je me geeft. Onvoorwaardelijk is je liefde, je steun en je vertrouwen in mij. Jij hebt 
me geleerd te vertrouwen in mijn eigen kracht, dat de wereld niet logisch is, maar bovenal 
heb je me geleerd te geloven in mezelf. Ik heb heel veel bewondering voor de manier 
waarop je, toen ik nog jong was, het voor elkaar kreeg mijn ouders te zijn, een opleiding te 
volgen en je eigen praktijk op te richten. You’re a badass. I love you. 
Lieve Carmen, querida,  hoe kan ik beter beginnen dan met een verhaal uit de griekse 
mythologie?
“Once, a long, long time ago, all people had four legs and two heads. And then, 
the Gods threw down thunderbolts, and split everyone into two. Each half then 
had two legs, and one head. But the separation left both sides with a desperate 
yearning to be reunited, because they shared the same soul. And ever since 
then, all people spend their lives searching for the other half of their soul.” 
Wat ben ik dankbaar dat ik jou gevonden heb. Ondanks initiële misverstanden over mijn 
beroepskeuze (ahem), slechte internetverbindingen en miereninvasies. Je was er, iedere 
dag, door de vele ups en downs. Je las geduldig mijn stukken (je weet waarschijnlijk meer 
van deciduale vasculopathie dan de gemiddelde arts), je maakte je kwaad voor me en je 
klaagde nooit als onze vrije tijd weer eens onderzoekstijd werd. Ik kan niet wachten op wat 
de toekomst ons gaat brengen. Mi media naranja. Ik hou van je. 
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Droïma Stevens werd op 3 februari 1983 geboren te Eindhoven. Zij studeerde aan de Vrije 
School Brabant te Eindhoven, waar zij op de locatie Nuenenseweg het basisonderwijs en 
op de Ambachtelijk Technische Bovenbouw het voortgezet onderwijs afrondde. In 2001 
reisde en werkte zij een jaar in Australië, alvorens aan het ROC Volwassenenonderwijs haar 
VWO diploma te behalen. In 2003 startte zij met de studie Geneeskunde aan de Radboud 
Universiteit te Nijmegen. In de wachttijd voor de coschappen reisde zij enkele maanden 
door Ecuador en heeft vrijwilligerswerk gedaan op de Galápagos eilanden. Tijdens het 
coschap gynaecologie in het Laurentius ziekenhuis te Roermond werd haar enthousiasme 
voor dit vakgebied aangewakkerd. In het Sengerema district hospital in Tanzania, waar zij 
haar oudste coschap doorbracht, groeide haar interesse in de gynaecologie. Zij deed haar 
Wetenschappelijke stage op de afdeling verloskunde en gynaecologie van het Radboud 
universitair medisch centrum onder begeleiding van dr. Salwan Al-Nasiry, en kon na haar 
afstuderen aldaar beginnen als ANIOS en onderzoeker. Haar onderzoek naar deciduale 
vasculopathie bij pre-eclampsie (DEVAP studies) werd begeleid door Prof. dr. John van 
Vugt, Prof. dr. Marc Spaanderman (MUMC) en Dr. Salwan Al-Nasiry (MUMC), in nauwe 
samenwerking met de afdeling pathologie (Dr. J. Bulten). Sinds maart 2014 werkt zij met 
veel plezier als ANIOS bij de gynaecologie in het Zaans medisch centrum te Zaandam 
(opleider Dr. N. Bayram).  In januari 2016 zal zij starten met de opleiding tot gynaecoloog in 
het Rijnstate ziekenhuis te Arnhem (opleider Dr. F.P.H.L.J. Dijkhuizen).
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